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It is becoming increasingly important to understand biological networks in order 
to understand complex diseases, identify novel, safer protein targets for therapies and 
design efficient drugs. „Systems biology‟ has emerged as a discipline to uncover 
biological networks through genomic data. Computational methods for identifying these 
networks become immensely important and have been growing in number in parallel to 
increasing amount of genomic data under the discipline of „Systems Biology‟. 
In this thesis we introduced novel computational methods for identifying 
topological and dynamic properties of biological networks. Biological data is available in 
various forms. Experimental data on the interactions between biological components 
provides a connectivity map of the system as a network of interactions and time series or 
steady state experiments on concentrations or activity levels of biological constituents 
will give a dynamic picture of the web of these interactions.  Biological data is scarce 
usually relative to the number of components in the networks and subject to high levels 
of noise. The data is available from various resources however it can have missing 
information and inconsistencies. Hence it is critical to design intelligent computational 
methods that can incorporate data from different resources while considering noise 
component.  
This thesis is organized as follows; Chapter 1 and 2 will introduce the basic 
concepts for biological network types. Chapter 2 will give a background on biochemical 
network identification data types and computational approaches for reverse engineering 





approach for recovering network topology and dynamics through noisy measurements. 
We proved our method to be superior over existing reverse engineering methods.  
Chapter 4 is an extension of chapter 3 where a Bayesian parameter estimation algorithm 
is presented that is capable of incorporating noisy time series and prior information for 
the connectivity of network. The quality of prior information is critical to be able to infer 
dynamics of the networks.  The major drawback of prior connectivity data is the presence 
of false negatives, missing links. Hence, powerful link prediction methods are necessary 
to be able to identify missing links.  At this junction a novel link prediction method is 
introduced in Chapter 5. This method is capable of predicting missing links in a 
connectivity data. An application of this method on protein-protein association data from 
a literature mining database will be demonstrated. In chapter 6 a further extension into 
link prediction applications will be given. An interesting application of these methods is 
the drug adverse effect prediction. Adverse effects are the major reason for the failure of 
drugs in pharmaceutical industry, therefore it is very important to identify potential 
toxicity risks in the early drug development process. Motivated by this chapter 6 
introduces our computational framework that integrates drug-target, drug-side effect, 
pathway-target and mouse phenotype-mouse genes data to predict side effects. Chapter 7 
will give the significant findings and overall achievements of the thesis. Subsequent steps 










                           




Most biological functions arise from complex interactions between cell‟s 
numerous components, such as, DNA, RNAs. metabolites and proteins.  These 
interactions form complex networks involving thousands of genes, proteins and 
metabolites. Understanding these networks helps scientists shed light on the complex 
diseases such as cancer and diabetes as well as control and manipulate biological 
functions in living organisms. Two important components of a network are the topology 
and dynamics. Topology refers to wiring diagram of the network, in other words it is the 
connectivity in a network. Dynamics of the network is the quantification of the 
connections and time course response of the networks. Many diseases are due to 
interaction of complex networks from different tissue and organ levels. It is important to 
understand both topology and dynamics of these networks to be able to identify novel 
targets for interventions that may help prevent or cure the diseases. A major challenge in 
biology is to map out and model the connectivity and dynamical properties of these 
networks.  
Motivated by this in this research we developed computational approaches for 
identifying biological networks. The goals in this thesis can be stated in two ways; 
Predicting network topology and dynamics to understand complex machinery of biology 
and finding missing and significant links that have various applications in getting a better 





networks, biological data types, important computational aspects and applications for 
reverse engineering. 
 
1.1 Types of Biological Networks 
At a highly abstract level the components of a living organism can be reduced to a series 
of nodes that are connected to each other by links, with each link representing the 
associations between two components. These associations can be in the form of  binding 
of one component to the other thereby affecting its function. In gene regulatory networks 
specialized proteins bind to genes to modulate their expression level. Drug target 
networks can be another example for this kind of association where a link represents 
binding between a drug and a target. In metabolic networks a component can catalyze 
reactions where each reaction and catalysis action of an enzyme on this reaction can be 
represented as a link in the network. The notion of a biological network can sometimes be 
extended for defining more abstract associations between biologically relevant 
components where the exact mechanisms are not yet known.  Drug side effect networks 
can be given as an example for this type of networks.  There are different kinds of 
biological networks that take part in different functions of the living organisms at 
different levels. In the next few paragraphs we will give brief information on each type of 
networks.  
Metabolic pathway networks are the series of reactions that share reactants and 
products. Enzymes catalyze these reactions and often require dietary minerals and 
vitamins and other co-factors in order to function properly. Because of the large number 





may exist within these networks.  A substrate enters a metabolic network leading to a 
series of reactions and the production of intermediates and final molecules. This final 
product molecule may be used as a substrate for another network.  
Protein-Protein interaction occurs when two proteins bind together often to carry 
out a biological function. These interactions are at the core of entire interactomics system 
of many living organisms. Signals from exterior of a cell are conducted to the cell trough 
through protein-protein interactions. This is also called signal transduction. Signal 
transduction networks refer to the interactions where an extracellular molecule activates a 
membrane protein that in turn alters a cascade of intracellular proteins creating a 
response. These molecular cascades detect, amplify and integrate diverse external signals 
to generate responses such as enzyme activity, gene expression, or ion-channel activity. 
Diseases may be due to malfunction of one or more signal transduction networks.  
Transcriptional regulation is the most common way in which cells use these 
interaction webs to perform its functions. This is achieved by cell‟s specialized proteins 
called transcription factors. A transcription factor or a combination of transcription factor 
can bind to an upstream of a gene and modify that gene‟s output. A gene‟s product is the 
mRNA (Messenger RNA ) and mRNAs are translated into proteins. Therefore, it is a 
higher level control mechanism in cell that can account for functional diversity of cells 
and it can control metabolic, transduction and protein interaction networks.  
In addition to these networks, more abstract level of biological associations is 
studied as networks. For example, drug – side effect networks are one of them. A side 
effect is an effect, whether therapeutic or adverse, that is secondary to the one intended. 





unintended but beneficial consequences of a drug though it commonly refers to its toxic 
results. Drug-target networks are another interaction webs where potential target proteins 
of drugs are collected and analyzed. In the pharmaceutical industry it is often important 
to analyze combination of these networks in addition to the molecular networks to 
identify novel targets and predict possible toxicity of developed drugs. 
 
1.2 Computational Methods for Biological Network Identification 
System biology has emerged as a discipline to understand and reverse engineer biological 
networks through biological data at a systems thinking level. It uses methods from 
mathematics, statistics, biology, information technology and the technology of high 
performance computing and the manipulation of large datasets.  This discipline is 
developing in parallel with the amount and quality of biological data becoming available. 
The approaches that are employed changes with respect to the amount of information 
available and the resolution and accuracy of prediction needed. A detailed modeling 
effort can include the differential equation representation of the network in continuous 
time domain. These methods usually target small portions of the network and they require 
topology information. Other methods include causal networks such as Boolean and 
Bayesian networks. Sometimes biological networks are simplified to bipartite network 
representations in the case of drug-target and drug-side effect networks.   
Recently, large amounts of diverse types of genomic data are obtained to shed 
light on these networks. For transcription regulation, e.g., DNA sequence data, micro-
array gene expression data, protein-DNA binding data are the major data sources. For 





network inference methods utilize protein-protein interaction data as well as protein 
phosphorylation data. There are several information resources available for drug-target, 
drug-side effect, as well as pathway-target networks. These resources are crucial for 
understanding diseases and designing novel drugs. Next Chapter will give a background 




























    CHAPTER 2 
 




This section starts with the definition of transcriptional regulation and elaborates on the 
data types and methods for inference of regulatory networks. Microarray technology is an 
experimental method where thousands of gene expression levels are measured 
simultaneously. This technology has created means to generate abundant data to shed 
light on gene networks [4]. Therefore, many efforts of biological network applications 
particularly focused on inferring gene regulatory networks from microarray data. The 
noise levels in microarray data is high [5] and only small portion of these studies 
concentrated on addressing this problem [62]. Hence, in chapter 3 we will develop 
identification methods of regulatory networks under noisy measurements.  
The second part of this chapter introduces the link prediction methods in 
biological networks. These methods are essential to uncover hidden connections and can 
be potentially used in improving the topology of networks. As biological networks are 
complex, connectivity information is crucial for reverse engineering methods. However 
this information can have noise in the form of inconsistencies, false links and missing 
links.  Link prediction methods are usually based on scoring a pattern or a link in the 
topology of the network and they can potentially be a remedy to improve the topology of 
the network. Common link prediction methods are based on the notion that nodes they 
share common features are more likely to be linked. These features are usually based on 
common number of nodes that are shared by pair of nodes, shortest path between the pair 





However there is no probabilistic approach that considers degree distribution of the nodes 
in a systematic and comprehensive way in the network when scoring the local structures 
in the context of biological networks.  In chapter 5 we introduced a score function based 
on a probabilistic framework to quantify links in biological networks. 
The last part of this chapter provides a background on drug-side effect network 
prediction methods as well as drug-target networks. These networks are commonly used 
by pharmaceutical industry to bring novel protein targets for drugs or to predict potential 
toxicity risks involved with them.  
 
2.1 Transcriptional Regulation 
 
Two foundational concepts in molecular biology are: (i) genes, the fundamental units of 
heredity, are encoded as sequences of chemical bases in DNA and (ii) a gene is expressed 
when its DNA sequence is transcribed into an RNA intermediate and then translated into 
proteins. Proteins, in turn, perform regulatory, catalytic, mechanical, and electrical 
functions [1].  
Gene expression is the process by which cells produce proteins from the 
information encoded in DNA [1]. The information flow from DNA to proteins occur in 
following steps: Specialized proteins transcribe a region of DNA (gene) into a Messenger 
RNA molecule, and RNA molecule is translated into a polypeptide chain, and 
polypeptides fold into three dimensional structures and modified with additional proteins 








Figure 2.1: Gene expression is shown as a three step process [2]. 
Initiation of transcription in eukaryotes is a complicated process that depends on the 
binding of transcription factors (TF) to the promoter region as well as the action of RNA 
polymerase complex to the transcription start site. Transcription occurs as a result of 
combinatorial and cooperative binding of multiple factors on the same promoter region. 
TFs regulate the transcription process either positively of negatively. Occupancy of a 
transcription region by a TF is a necessary but not sufficient condition for that gene to be 
activated or inhibited. 
 
 
Figure 2.2: Transcription process by transcription factor and RNA polymerase action 
[67]. 
The process of gene expression allows for control at many levels. Changing the 
rate of transcription into a RNA molecule, stalling the process of its translation into 





controlling the gene expression. Cells have evolved to use all of these mechanisms, but 
regulation of the transcription process is the most common. Transcription factors are the 
proteins that can bind to the DNA in order to regulate this process [1]. 
Genes, proteins, and metabolites can regulate one another in various ways. 
Regulatory proteins bind to a DNA molecule to affect the transcription of genes. Proteins 
can also combine to form multi-protein complexes that can take part in various functions 
in regulation, for example unzipping a DNA molecule or cleaving an RNA molecule. 
Metabolites can also attach proteins to alter their activity level [1]. 
2.2 Data types on gene networks 
Previous section gave a description of gene regulatory networks. This section will 
introduce types of experimental data that are used for understanding gene networks. 
Microarray and protein-DNA binding experiments are two major data sources for 
regulatory networks. 
2.2.1 Micro-array data 
Micro-array is a chemical assay that uses fluorescent labeling to measure the RNA 
concentrations of all the genes in a cell in single experiment. A micro-array includes 
thousands of distinct chemical probes, each specific for a gene‟s RNA, arranged on 
silicon or glass substrate in the size of a coin [1]. Total RNA is fluorescently-labeled and 
washed over the chip and the chip is illuminated. Each probe will fluorescence according 
to how much labeled-RNA is bound. Therefore, fluorescence pattern on the chip provides 
a global picture of gene expressions for a given experiment. Unlike physical binding 
interactions between molecules, micro-array experiments only provide indirect evidence 





DNA micro-arrays have been used to measure mRNA abundance for essentially 
all protein-coding genes in the genome under a large number of conditions. These data 
provide measurement of expression levels of thousands of genes simultaneously, and 





Figure 2.3: A DNA micro-array is a collection of DNA fragments attached to a solid 




Figure 2.4: A DNA micro-array data is shown. Each dot corresponds to the mRNA level 
for a specific gene with respect to a reference level. Red color shows an increase in 
expression level, green color indicates a decrease, and black color corresponds to an 






There are two kinds of micro-array data obtained to infer gene regulatory 
networks: Steady-state measurements and time-course data.In steady-state data, upon a 
single gene knockout, over expression or simultaneous perturbation of a group of genes, 
the system reaches to a new steady state. The gene expression levels are measured against 
the reference steady state values. In algorithms using steady state data, a major drawback 
is the necessity of keeping the perturbation levels sufficiently low to render final results 
reliable. 
In time-series data, the system is perturbed and measurements of gene expression 
levels with respect to unperturbed level are obtained in successive time points. Compared 
to steady-state data, time series offer rich opportunities for understanding the dynamics of 
biological processes [6]. 
Limitations of micro-array data 
Micro-array data is scarce for the gene regulatory networks inference methods which 
require large data set. These data are expensive to obtain and include experimental noise 
up to 15% . In other words, micro-array data are typically noisy, high dimensional, and 
significantly undersampled [2]. 
2.2.2 Binding Data 
Chromatin immuno-precipitation (ChIP) is an experimental method in molecular biology 
to quantify the occupancy of upstream non-coding regions by transcription factors. In 
budding Yeast Saccharomyces Cerevisae, ChIP has been used to globally map the 
binding sites over a hundred transcription factors [7].  
 





Occupancy of the promoter region of a gene by a transcription factor protein is necessary 
but not a sufficient condition for a gene to be regulated by it [7]. As a result, 
quantification of genome wide transcription binding patterns by ChIP experiments alone 
can only indicate the potential for a gene to be regulated by a given TF [7]. Independent 
information will be required to establish that the gene is indeed a functional target. 
Binding of a TF on a promoter region of a gene is leads to observation of a link between 
for that TF-gene pair from the perspective of a network. However as binding of a TF 
protein to a gene doesn‟t necessarily mean regulation of this gene by TF protein this link 
is considered as a false link. Binding data has been obtained for a limited number of 
organisms. So far, protein-DNA interaction quantification has been studied for K12 
E.Coli [8], and for yeast.  
The microarray and protein-DNA binding data may not be sufficient for a detailed 
reverse engineering of the gene networks due to the high number of TF proteins, genes 
and mechanisms involved in these networks. Therefore researchers resort to certain 
abstractions in inference algorithms. Next section will give the details of such 
simplifications and assumptions.  
 
2.3 Main assumptions in gene network inference algorithms 
 
Gene networks contain the complex and nonlinear interactions of proteins, metabolites 
and genes. However, micro-array data provides only mRNA concentration information. 
Protein and metabolite concentration (proteomics and metabolomics) data are still 
difficult to obtain. As a result, network inference methods based on micro-array data can 
only capture the regulation dynamics in an indirect manner [10, 1]. In other words, all 





factor genes can be used as a proxy for the true transcription factor activity-the 
concentration of the protein in the form of that is able to bind and induce/repress 
transcription [10]. Nevertheless, algorithms based on revealing gene to gene relations, 
provides a global view of gene regulation [2]. 
Another challenge is the scarce nature of micro-array data. The reverse 
engineering approach requires large amounts data and extensive computational resources 
[11]. Typically, there are a huge number of network topologies that fit a given set of 
expression data [11]. To circumvent this problem, many research efforts have focused on 
clustering,.i.e grouping genes into hierarchical functional units based on correlations in 
expressional patterns [12, 13, 14]. A fundamental shortcoming of the clustering approach 
is that they are based on the assumptions that: gene regulatory networks are hierarchical 
in the structure and genes performing related biological functions exhibit similar 
expression patterns. These assumptions may not always be valid [15].Due to data 
scarcity, several studies have targeted small networks using many different frameworks. 
The most popular way to get around the scarce data problem is the assumption of 
sparse connectivity in gene networks. This assumption greatly decreases the number of 
parameters to be inferred thus let researches tackle otherwise underdetermined problem 
[15]. However, this comes at the cost of computational complexity; a heuristic or Monte 
Carlo search for the best combination of regulators of each transcript is required.  
One of the main challenges among gene regulation inference is the validation of 
the method. Upon application of methods on experimental data, researchers try to 
validate their method by delving into biological literature. While this approach can give 





about the phenomena under study. For this reason, researchers usually apply their 
algorithms on well studied, usually small size networks.  
As a second approach, the algorithms are applied to synthetic data sets. In order to 
obtain an objective validation for the methods proposed, Mendes et al introduced a 
nonlinear continuous differential equation model that mimics characteristics of known 
gene networks as much as possible [16] (See Section C.1). Researchers measure the 
performance of their algorithms against synthetic data by various ways. The two common 
ways of measuring performance is the coverage of connections (true positives) and false 
positives in recovered network. True positive ratio is the proportion of the number of 
correct connections identified to the total number of connections in the true network. 
False positive ratio is the proportion of incorrect connections in recovered model to the 
total number of recovered connections. [17]. 
2.4 Reverse engineering strategies for gene networks 
Engineers and scientists have previously developed reverse engineering techniques in the 
fields of computer science, engineering, and statistics, which are respectively called 
machine learning, system identification and statistical learning [75]. With the emergence 
of DNA micro-array data, researches proposed many approaches to reverse-engineer the 







Figure 2.5:  General Strategy for reverse engineering transcription control systems [2]. 
Several approaches have been proposed to reconstruct the gene regulatory network from 
the data. One can broadly group these methods in two categories: Stochastic and 
deterministic approaches.  
2.4.1.1          Stochastic Approaches 
 
Many stochastic approaches have been proposed to reverse-engineering of gene 
networks. Among these, Bayesian Networks and Dynamic Bayesian networks are the 
most popular ones.  
2.4.1.2 Bayesian networks 
Bayesian network is one of the popular frameworks that have been applied successfully 
for gene networks. Bayesian network methods were first proposed by Friedman et al. 
[18], and further developed by Hartemink et al [19].  
A Bayesian network is a graphical model that represents the causal relationship in 
random variables [70]. In the context of gene networks, each gene represents a node in 
the graph and expression level of each gene is represented as a continuous random 





conditionally dependent on the expression levels of other genes. In a Bayesian 
framework, the task to infer the network is to identify the weight of these dependencies 
[1] (Section A.1). 
The probabilistic structure of a Bayesian network enables straight-forward 
incorporation of prior knowledge via Bayes rule, thus one can complement the micro-
array data with prior information.  
The network structure is usually determined using heuristic search, such as a 
greedy-hill climbing approach or Markov-Chain Monte Carlo method [76]. For each 
network structure searched, algorithms find the maximum likelihood parameters and 
compute a score for each structure using Bayes rule. The Bayesian network approach 
typically requires a vast data set and it can-not handle cycles in the network [1]. 
 
 
2.4.1.3 Dynamic Bayesian networks 
 
Dynamic Bayesian networks represent the dependency in gene expression levels based on 
time-course data. The directed graph of the causal relationship among N  random 
variables is then constructed by estimating the bipartite graph of transcription factor 
proteins and genes. (See Section A.2). A Hidden Markov model can be considered as the 
simplest dynamic Bayesian network [65].  
Bayesian network is a quite powerful method to model networks however they 
require a vast amount of data. Data is scarce in biological networks [2] and subject to 
high levels of noise [66]. Therefore, Bayesian networks can only target small networks 
whereas linear and deterministic models are capable of identifying larger networks. The 






2.4.2         Deterministic Approaches 
 
Most studied modeling schemes for gene networks are deterministic approaches. The  
methods of ordinary differential equations and Boolean methods are two of the most 
popular deterministic methods employed for the inference of gene networks. 
 
2.4.2.1 System of differential equations 
The most common approach to the modeling of dynamics of gene regulation is to view a 
gene regulatory network as a biochemical network of gene products, typically mRNA and 
proteins, and to describe their rate of changes through a system of ordinary differential 
equations[6, 15, 21, 22, 24, 28]. Therefore, the modeling framework is that of continuous 
time and, deterministic dynamical system often cast as ordinary differential equations 
(ODEs). (See Section B.1). 
Linear Methods 
In many studies using ODEs, the main underlying assumption is that the system is 
operating near a steady state, so that dynamics can be approximated by linear differential 
equations (See Section B.1).Several groups have applied linear ODE models to infer gene 
networks [15, 21, 22]. These methods usually require a certain degree of prior 
information. One of popular approach is to infer networks using steady state data on 
linear models [22, 23, 6]. Gardner et al. [22] proposed NIR (Network Identification by 
Multiple Regression) algorithm to reverse engineering a SOS network (DNA damage 
response pathway) using linear ODE model structure and steady state measurements. In 
the study of Gardner et al. [22], experimental data are collected by artificially increasing 





settles to a new steady-state. The response of the system is calculated by the shift of the 
state variable from the initially observed steady-state. Though steady state data models 
can shed light on the structure of the network, they cannot give details on the dynamics of 
the networks.  
In Bansal et al [21], an algorithm to infer gene networks is proposed. They used 
time series data instead of steady state perturbations. They perturb a gene of interest and 
subsequently measured the gene expression profiles at multiple time points. However 
their model didn‟t consider any noise element in their study. In their method they 
identified the parameters (regulatory strengths in the network ) in the discrete domain and 
transform estimated parameters into the continuous domain. Noise in the data will lead to 
noisy parameter estimation in discrete domain and this error is further amplified when the 
system is transformed into the continuous domain. Therefore it is crucial to consider 
noise and any possible correlation structure in it.  
S-System based models 
 
Genetic networks are complex nonlinear systems.  The S-System is one of the best 
formalisms to estimate mechanism of interactions in gene regulation.  It is one of the 
most well studied methods [24-28]. The structure of S-System is rich enough to capture 
many relevant biological dynamics.  
The S-system belongs to the type of power-law formalism because it is based on a 
particular type of ordinary differential equation in which the component processes are 
characterized by power-law functions [28, 29]. (See Section B.2 ).  
The major disadvantage of S-System formalism is that it requires a large number 





gene regulatory network applications, where the data is highly limited, only small size 
networks can be the target of estimation by S-Systems.  
 
2.4.2.2 Boolean Networks 
First proposed by Kaufman (1969), Boolean networks represents gene networks as 
logical switching networks; it is a coarse grain approximation of the real network. In this 
model, time is taken discrete and gene expression is discretized into two qualitative 
states, present or absent. Several algorithms have been proposed for inferring Boolean 
networks [30, 31]. The goal is to construct an algorithm to find an optimal Boolean 
function for the given state data. A sparseness assumption is made to make the problem 
tractable under scarce data. The number of inputs to a function is limited to a certain 
degree. The main disadvantage of the Boolean algorithm is that it loses large amounts of 
information as the expression levels are reduced to only ON/OFF.  
True behavior of biological networks are highly nonlinear, therefore nonlinear 
ODE approaches such as S-Systems can model networks accurately. The major issues 
with nonlinear modeling efforts are the number of parameters to be estimated ,data 
scarcity compared to network complexity, and the difficult of constraining model 
behavior outside the range of measured data so that reasonable generalization error 
results. On the other end of spectrum sits Boolean methods. They are very simplistic 
representation of network interactions. Though they can give an idea about the initial 
picture of the networks they are far from providing dynamic details of the system. Linear 
continuous and discrete time models can give enough details with reasonable data 
requirements. However the majority of these models do not consider the noise component 





topology and parameter estimation. Furthermore, these methods assumed known 
topologies or didn‟t use topological information available from different resources.  
 
2.4.3 Methods integrating diverse types of genome data 
 
Some research has been directed to reveal the transcription factor activities using  micro-
array data alone or with binding data [ 7, 10, 32- 40]. Liao et al. [32] proposed Network 
Component Analysis (NCA) to infer transcription factor activities, which can incorporate 
prior knowledge. However, the NCA method imposes strong restrictions on the network 
topologies. Alter and Golub [40] introduced an approach for integrating binding and 
micro-array data using pseudo-inverse projection. 
Boulesteix and Strimmer [35] proposed a statistical approach based on partial 
least squares regression to infer the true transcription factor activities from a combination 
of mRNA expression and DNA-protein binding data. 
Gao et al [7] presented MA-Networker algorithm that combines micro-array and 
binding data and infer the activity of transcription factors using multivariate regression. 
Brynildsen et al. [34] proposed a Gibbs sampling algorithm combining two types of data 
which concentrates on the instances of agreement of both data. By doing this, they aimed 
at minimizing the effects of experimental noise in the data, and lack of correlation 
between binding and regulation. 
Sabatti and James [37] introduced an algorithm using sequence and expression 
data to infer transcription factor activities. They used sequence data to define a prior 
distribution on the topology of the network and expression array data allows them to 
identify which of the potential binding sites are actually used by regulatory proteins and 





Bayesian framework to identify unknowns in a linear model [37]. In matrix notation, 
their model is represented as follows; 
 PAE                             (2.1) 
where E  represents the micro-array data. In   MNijeE

  row indices correspond to the 
gene numbers and each column represents an experiment at a different time point. N  is 
the number of genes and M is the number of experiments.      LNijaA

  is the regulatory 
strength  matrix denoting the effect of TF proteins on gene expression. L is the number of 
transcriptional proteins. Each element, ija  shows the regulatory effect of the 
thj  TF 
protein on the expression of the thi gene ( mRNA level ). A is usually a tall matrix as the 
number of TF proteins is smaller than number of genes. ( NL  ). It is unknown along 
with the   MPjtpP

   matrix representing TF levels at different time points.   MNit

   
captures the measurement error in each gene expression level. Each it s assumed to be 
i.i.d  according to the Gaussian distribution,  2,0 iN  .  
  LNijzZ

  is a binary matrix with  element ijz  is 1 if 
thj  TF factor is regulating thi gene  
and zero otherwise.  
The Bayesian reconstruction framework becomes as follows; 
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In this reconstruction framework, the unknowns are A  the regulatory strength 
matrix, Z the binary version of A  and P  is the TF protein levels in different time points 
and 2 is the variance vector storing the variances of measurements of each gene‟s 
expression level. 
ia  and 
iz  represent the thi column of A  and Z matrices respectively. 
tp  is the vector of elements in P  matrix in row number, t . The vector form is adopted 
in order to have a compact representation for the expressions. The posterior distributions 
of Z , A  , P and 
2 are obtained according to the Bayesian rule shown in equation (2.2). 
ija , jtp  and 
2
i  assumed to be mutually independent with following distributions; 
   2,01|Pr aijij Nza            2,0 pij Np   







                                           (2.3) 




p  are assumed to be hyper parameters. In the 
presence of a regulatory relation ( 1ijz ), the regulatory strength term, ija has Gaussian 
distribution with zero mean and a variance of  2a  . Zero mean indicates that there is no 





with zero mean with a variance of 2p . The distribution on each element of binary matrix, 
Z  is considered to be binomial with parameter, ij . This parameter is obtained through 
sequence information. The difference between model and measurement is also assumed 
to have Gaussian distribution with zero mean shown in the first term in the right hand 
side of  equation (2.3). 
Sabbatti and James used a collapsed Gibbs Sampling algorithm to solve the 
problem sequentially and applied their methodology to the E.Coli expression data. Sun et 
al. [38] introduced a Bayesian error analysis model to integrate binding and gene 
expression data to reconstruct transcriptional regulatory network. In their algorithm, they 
accounted for measurement errors in both types of data by considering these within a 
Bayesian model framework. Transcriptional factor activities and their effect on genes 
defined as parameters and along with unknowns defined for error models are merged in 
this framework [38]. 
Sun et al‟s method is a slightly different version of the approach employed by Sabatti and 
James [37]. The major contribution in the paper is modeling transcription process as a set 
of biochemical reactions and ending up with the identical linear model between 
expression levels and TF protein that was adopted in [37] ( Equation (2.1) ).  They also 
assumed measurement noise has independent structure and Gaussian distribution where 
the variances are among the unknowns in the inference algorithm.  Unlike in [37], instead 
of Gamma distribution, they assumed an inverse gamma distribution on the variance of 
measurement noise.  
Their model is identical to equation (2.1). Instead of sequence data, they used 





consisting of two components; a binary connectivity matrix,  ijrR   and regulatory 
strength matrix,  ijaA   ( equation (2.1)). R is binary version of A  and essentially 
shows the presence and absence of the edges in the network where nodes representing 
gene expression and TF levels. Through protein-DNA binding data, the observed binary 
binding information  ijzZ   is obtained. This Z  matrix is analogous to the Z  matrix in 
[37], but note that Sabatti and James obtained this observation through sequence analysis 
instead of protein-DNA binding data. 
 As Z  has observational errors (false positives and false negatives), they 
introduced an misclassification model between Z and R  ( observed and real binary 
binding matrices , respectively). Their misclassification model is as follows; 
  prw ijij  1|1Pr                     prw ijij  11|0Pr  
  qrw ijij  0|0Pr         qrw ijij  11|0Pr                                              (2.4) 
 
where p  and q  are true positive and true negative rates respectively. They obtained 
relative binding intensity data through protein-DNA binding experiments and represented 
it as,  ijbB  . The regulatory strength, ija  is approximated by using binary binding 
information, ijr and binding intensity, ijb according to the following formula; 
ijijij rba                           (2.5) 
In [37], there was no binding intensity information, and regulatory strengths ija  
have Gaussian distributions with zero mean (Equation (2.3)),  however in this study , 





 MCMC is employed as a solution strategy similar to [37]. The method is applied to the 
yeast cell data to illustrate its application.  
In both of these studies [37, 38], the nodes of the gene network are the gene 
expression levels and TF protein levels. TF protein levels are treated as unknown hidden 
variables and expression levels are the variables observed through time series micro-array 
data. 
As genomic data is limited, corrupted by high levels of noise and systems are 
complex, prediction TF protein levels for all time points in addition to regulatory 
strengths may result in inefficient reconstruction. TF protein levels as hidden variables 
will provide additional information on networks, but comes at the cost of higher quality 
and quantity of data. 
In another study Bernard et al [39] presented a dynamic Bayesian method for 
jointly learning models of transcriptional regulatory network from expression and binding 
data. They incorporated expression data in likelihood term and binding data is modeled in 
a probabilistic manner to serve as a prior. Dynamic Bayesian networks is a class of 
Bayesian network model that permit cyclic structures like regulatory feedback loops and 
have been used to analyze the time series data in the context of transcriptional regulation 
[20]. In the process of learning dynamic Bayesian networks, most probable topology is 
determined using Bayes rule given the time-series data. (For detailed discussion of 
Dynamic Bayesian Networks , see section  A.2 in appendix ). The prior on structures is 
usually assumed to be non-informative. In [39], binding location data is used and 
converted to a probabilistic model to serve as an informative prior. Location data 





signified through p-test. In their probabilistic informative prior model, the more 
significant the location data (the lower the p-value), the more likely the edge is to be 
included).  They employed a function that maps p-values to corresponding probabilities 
of edges being present in the topology, G  of the gene network. In this network, the 
vertices (nodes) are gene expression levels and edges denote the regulatory relationships 
between the genes.  The p-value is defined as a random variable iPr in the interval,  0,1 . 
It is assumed to be exponentially distributed if GEi  , and uniformly distributed if iE  
















|PrPr                       (2.6) 
The probability of GEi   is taken as  ,   GEiPr . Using Bayes rule, the 
probability of edge iE  being present in  G after observing the corresponding p-value is 


















ii                                (2.7) 
 
They applied their framework on both simulated and experimental data and demonstrate 
that regulatory networks recovered through joint learning algorithms from multiple types 
of data are more accurate than those reconstructed from each type of data alone. However 








2.5  Link Prediction Methods in Biological Networks 
With the advent of new technologies in biology, there are many resources for data types 
for biological networks. Some of this data represents the connectivity structure of the 
biological networks. These networks can be listed as protein-protein interaction, 
regulatory and metabolic networks. For example, Text mining data identifies biological 
relationships based on co-occurrence of gene/protein/drug/disease terms in the abstracts 
of scientific publications [48]. Protein-DNA binding data is another resource for 
connectivity of regulatory networks. PPI (protein – protein interaction) databases are also 
quite commonly used for inference of networks. Recently link prediction has attracted 
increasing attention from network from computer scientists and physicists [57-61]. The 
link prediction problem can be categorized into two groups. The first category concerns 
predicting links that exist yet are unknown. Biological network connectivity prediction 
can be classified under this category. The other link prediction category is predicting 
connections that will become available in the future for networks evolving in time such as 
social networks [49]. For biological networks the discovery of a link is costly and time 
consuming therefore it is logical to make prediction using existing links and focus on 
verifying these predicted links.  
For link prediction first step is to define node similarity in the network depending 
on the commonly shared features. Lieben-Nowell and Kleinberg [50] compared topology 
based node similarity indices for social networks. They showed that Common Neighbors 
(CN) and Adamic Adar (AA) methods are the best in terms of predicting future links in 
social network examples. Common Neighbors method assumes that two nodes are more 





     yxCNScore            (2.14) 
Here,  x  is the set of nodes connected to node-x and similarly  y  is the set of 
neighbors for node-y.  
Adamic-Adar (AA) similarity index is a modification of common neighbors where the in-
degrees of common neighbors are taken into account. It is represented as follows;  
 








                                                   
(2.15) 
Jaccard is another quantification of similarity index between two nodes in a 
network. It is simply the number of common neighbors divided by the union set of 
neighbors of the pair of the nodes. Therefore, it is a function of out-degrees of the node 
pair as well as number of common neighbors they have.  
 
   





                       (2.16) 
Common Neighbors method only relies only on the number of commonly shared 
nodes therefore it doesn‟t consider degree distribution of the nodes. Jaccard index was 
originally introduced for comparing the similarity between two sets. It is also commonly 
used in graph theory.  For the Jaccard score out-degree of the nodes are considered in 
addition to the number of common neighbors.  On the other hand, Adamic Adar method 
is based on both number of commonly shared nodes and natural logarithm of their degree 
distribution. However this method doesn‟t take into account the out-degrees of the nodes. 
To the best of our knowledge there has been no study on p-value based probabilistic 
approaches for scoring node similarity based on the all three components; out-degree, in-
degree and number of commonly shared nodes . We will present such a method in 






2.6  Biological Networks as Bipartite Networks 
There are several other biological networks that can be represented in the form of 
bipartite networks. Among them is Drug-target networks.  Identification of drug-target 
interactions (interactions between drugs and target proteins) is a key area in drug 
discovery. Both the number of new drugs and targets has remained rather relatively 
unchanged in the last 20-25 years [51]. Yamanishi et al [52] integrated know drug-target 
information with target protein sequence data and drug chemical structure. In another 
study, Campillos et al [53] used side effect similarity between drugs to predict novel 
targets for drugs. They based their method on the assumption that the drugs that share 
common side effects are more likely to share targets. They combined drug-target, drug-
side effect information with drug chemical similarity. They also validated some of their 
predictions with experimental results. Drug-target information is available through 
different databases. KEGG brite [54], BRENDA [55] and Drugbank [56] are among these 
databases.  
Increasing scientific, regulatory and public scrutiny is focused on the obligation of 
the medical community, pharmaceutical industry and health authorities to ensure that 
marketed drugs have acceptable benefit-risk profiles. In that regard adverse event 
prediction methods for drugs become increasingly important. Drug side effects 
relationships can also be visualized as a bipartite graph. Campillos et al [53] defined a 
similarity measure for drug-drug pairs for their commonly shared side effects. They also 
created a drug-side effect database using drug package inserts (SIDER,[53]). Drug 





the order of thousands. Another database for drug-adverse event is AERS that is 
maintained by FDA. The name AERS stands for Adverse Event Reporting System.  It is a 
collection of Spontaneous reports that are product of surveillance of drugs in the post 
marketing phase. Hence, this database includes exposure of much larger population of 
patients compared to clinical trial data [74].  
It is essential to identify adverse events in the early phases of drug development. 
Two of these early phases include target discovery and animal models. An important 
parameter in target discovery is the side effect [71]. Pathways are crucial components in 
target validation. The knowledge of a pathway allows separate targeting of upstream or 
downstream targets. Inhibition or modulation of selected targets in the same pathway 
could lead to the same therapeutic with fewer side effects or better druggability. 
Furthermore, knowledge of pathways and their relation to each other helps researchers 
understand side effect profiles [71]. A valuable resource for biological pathways is the 
KEGG pathway database [54]. This is a collection of manually drawn pathway maps 
representing the collected knowledge on the molecular interaction and reaction networks 
[54]. This database can be viewed as a bipartite network of the Pathway-Target 
associations.  
In chapter 6 by integrating Pathway–Target relations (ex. KEGG pathway [54]), 
Target-Drug ( ex. Drugbank [56] and Brenda [55] ) and  Drug –Side Effect ( ex. 
SIDER,[53] and AERS ) we formed a multipartite network of Pathway-Target-Drug-Side 
Effect relations.  Integrating these databases and finding significant structures in these 
resulting networks can serve as a framework to associate side effects with targets and 





the early phases of drug development. To the best of our knowledge there has been no 
systematic study of integrating these databases on a network framework to find 
significant Target-Side Effect or Pathway-Side Effect relations.  
 Animal models have specific characteristics that mimic human diseases. The 
technologies for the creation of transgenic animals, where certain genes are either 
deleted, modulated, or added, have progressed tremendously in the last decade. As a 
result, the predictive power of animal models for human disease and pharmacology is 
improving. It is crucial to note that some experts in the pharmaceutical industry and the 
U.S. Food and Drug Administration (FDA) believe that inadequate animal models, or the 
lack of animal models altogether, are a major obstacle in drug discovery and 
development. Pharmaceutical companies have long used model organisms in preclinical 
efficacy [71]. The laboratory mouse is the premier animal model for understanding the 
genetic and molecular basis of human biology and disease
 
[72]. MGI database is a 
comprehensive information source that primarily provides genetic and genomic data to 
support laboratory mouse a model organism. [73] To achieve this goal, MGI maintains a 
comprehensive catalog of mouse genes and other genome features and associates these 
features with orthologous genes in other mammals, human diseases, functional 
annotation, mouse phenotype descriptions, DNA and protein sequence data and 
developmental gene expression information.  
A valuable information resource that can be obtained from MGI database is the 
mouse phenotype-mouse gene associations. These relations can be represented as a 
bipartite network. Combination of „Mouse Phenotype’-„Mouse Gene’ relations and 





effect network can give a multipartite network of Mouse Phenotype -Mouse Gene-Human 
Target-Drug-Side Effect.  In chapter 6 we will aim at finding significant motifs in such 
networks that can be used as a methodology to associate mouse phenotypes with human 
side effects. There is no network based method for associating mouse phenotypes with 
human side effects.  
2.7     Discussion 
In this chapter a background is given for reverse engineering biological networks. There 
are two broad groups of models for inferring biological networks; probabilistic and 
deterministic. Probabilistic models can give important details however in general these 
methods require a lot of data. This can result in insufficient inference accuracy as 
biological data is scarce, noisy and systems are complex. In deterministic models 
nonlinear modeling approaches such as S-Systems can explain biological data well 
enough however these models have many parameters and they can only target relatively 
smaller size networks. Linear ODE models can involve larger networks with reasonable 
accuracy. Much of the research on these models however didn‟t consider high noise 
component in biological networks. We introduced a novel constrained total least squares 
formulation based on a linear discrete ODE model in Chapter 3 to specifically address 
this problem.  
As biological data become abundant more data has been collected to shed light on 
connectivity of biological networks. There have been several studies on combining 
topology data with dynamic measurements and details of some of these studies are given 
[37-39]. For example, in studies [37, 38] binding or sequence data can provide initial 





noisy and systems are complex, estimating TF protein levels for all time points in 
addition to regulatory strengths may lead to poor reconstruction accuracy. Estimating the 
levels of Transcription Proteins may give a better picture for understanding regulatory 
networks, but it comes at the cost of higher quality and quantity of data. In [39] Bayesian 
networks are employed to integrate the data but since they are probabilistic frameworks 
the data requirement can be high and for limited data it can lead to poor performance. In 
chapter 4 we introduced a Bayesian parameter estimation framework that integrates 
connectivity and dynamic data. In our model gene to gene connectivity is considered. By 
doing this, we mainly focus on distributions of regulatory strengths between TF genes 
and target genes. These gene levels can be obtained through the microarray data.  
Due to complexity of biological networks accurate prior connectivity information 
is essential to be able to reverse engineer these networks. Missing links in the 
connectivity information can be a major hurdle for prediction of these networks 
dynamics. Therefore predicting missing connections in the networks becomes crucial. 
Link prediction methods are essentially based on estimating links between a pair of nodes 
depending on the commonality of their topological features.  Common Neighbors is a 
standard method of link prediction. It only relies only on the number of commonly shared 
nodes between the pair of nodes therefore it doesn‟t consider degree distribution of the 
nodes. Jaccard index is a variation of CN method in which out-degrees of the nodes are 
considered in the score function.  Adamic Adar method is based on both number of 
commonly shared nodes and natural logarithm of their degree distribution but this method 
doesn‟t take into account the out-degrees of the nodes. There has been no study on p-





all three components; out-degree, in-degree and number of commonly shared nodes. In 
chapter 5, we introduced a novel link prediction method based on a probabilistic 
approach. 
Many biological networks can be represented as a multipartite network that is a 
combination of several bipartite networks. Predicting significant links on these networks 
can have many potential applications. One important application can be drug side effect 
prediction. Side effect prediction has not been studied from the perspective of networks. 
In chapter 6, we introduce a framework for side effect prediction from targets, pathways 





















A NOVEL CONSTRAINED TOTAL LEAST SQUARES METHOD FOR THE 






A detailed overview of biological networks, data types, and computational methods was 
given in the previous chapter. There are two main issues with network identification 
problem; inference of topology and dynamics. Biological data is quite noisy and can be 
scarce. Furthermore, topological information can be incomplete, inconsistent or unknown 
for many biological systems. Therefore, in this chapter we address the problem of 
biological network identification without prior knowledge on connectivity only using 
noisy time series data. Least Squares is a commonly used method as parameter estimation 
framework for this kind of problem. However a discrete time model for this identification 
problem will lead to noise in both dependent and independent variables. Moreover, this 
error is serially correlated. To address this problem we propose a novel constrained total 
least squares algorithm. We demonstrate its superior performance over commonly used 
regression techniques such as least squares (LS), total least squares and existing 
Constrained Total Least squares approaches [64] on artificial network examples. 
  
3.2 Introduction 
The functions of living organisms are achieved through interactions of cell‟s components. 
These interactions create large networks. It has become essential to understand these 





networks sit at the core of these diverse networks and they have been studied intensively. 
Since the advent of diverse genomic data techniques from mathematics, statistics, 
engineering and computer science methods have been proposed to understand the 
topology and dynamics of regulatory networks. These methods are collected under the 
umbrella of “Systems Biology” that has emerged as an interdisciplinary science.  An 
outstanding addition to the ability to generate genomic information is the microarray 
technology, and the majority of network inference efforts are focused on reverse 
engineering regulatory networks from time series measurements [6,15,21, 22, 24, 28]. 
These studies model the dynamics of gene regulation as a biochemical network of gene 
products, typically mRNA and proteins, and  describe their rate of changes through 
system of ordinary differential equations. Since the time series experiments are available 
in discrete time points inference methods are developed as discrete time equations. In this 
type of model the expression level of a gene is assumed to be the concentration of its 
transcript. The concentration of a particular transcript at time point 1k , 1ˆ kix is given by 















1 ˆˆ ,   Ni ,..,1     2,0 eki N                     (3.1)     
                 
 
where N is the number of transcripts in the network and ija  is the regulatory strength 
between gene pairs i  and j .  ki  is the error term for the difference between observation 
and the model. The errors are assumed to have Gaussian distribution with zero mean and 
standard deviation of 2e . The input term for this model is represented as 
k
iu . The aim is 
to estimate parameter values, ija ‟s,  from micro-array observations, 
k





reconstructing the gene network. A negative ija  indicates an inhibition, and a positive 
value for ija  stands for activation between the gene pair. In general, only a small subset 
of all RNA species regulates a particular transcript, which means most of the ija ‟s are 
zero. In other words, the gene networks are sparse. [4]. 
Microarray data is usually subject to high levels of additive and multiplicative 
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In this equation, kix  is the unknown true value for concentration of 
thi gene at 
thk  time 




i ux  and 
k
iv  correspond to 
multiplicative and additive parts of the measurement error. 
Using equation (3.1) and (3.2), one can write the model for all genes,  
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where ,  TkNkk xxx ,...,1
  ,  TkNkke  ,...,1  ,  
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N
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Equation (3.3) can be written for all time points, Mk ,...,1 , as follows;  
  UEXAEX  122                         (3.4)  
 
where  MxxX  ,...,22  ,  
  111 ,...,  MxxX
 ,   MeeE ,...,22  ,and  111 ,...,  MeeE . 
 
One can see that both dependent and independent variables have error terms (Eq.3.4). 
Furthermore 1E  and 2E  are serially correlated as they have same columns except for the 






Majority of inference algorithms for discrete time models focused on least squares 
regression. Least squares assume error terms are limited to only dependent variables. A 
significant problem from the regression standpoint is that both independent and 
dependent variables have high level of noise. Moreover, these noise terms are serially 
correlated. Noise has significant impact on parameter estimation of the networks. It is 
obvious that more advanced inference algorithms are needed that can take into account 
critical noise component. Kim et al [64]. proposed an application of constrained total 
least squares algorithm (CTLS) that is ideally suited for this model formulation. As seen 
in Equation (3.4) the models is corrupted by noise in both sides of the equation and noise 
is serially correlated.   In their CTLS approach for a multi-variable network model, 
parameter estimation for each dependent variable is calculated separately. However since 
error propagates in time with parameter matrix (Eq. (3.3)) one should estimate parameters 
for dependent variables simultaneously. We introduced a novel CTLS algorithm that 
takes care of correlated noise and estimates parameters for dependent variables 
simultaneously. We compared our methods with Kim et al [61]‟s examples as well as 
other common regression methods. We observed significant improvement over traditional 
regression models and their CTLS framework.  
 
3.3  Methods 
We adopt a  linear discrete time model for gene regulatory network . All equations are 
written for all M  data points and N  nodes in a state space representation. States refer to 
the values of expression levels and errors representation experimental error.   






In this representation the observation for dependent and independent variables are 
decomposed into true value and error terms. 
In this equation state matrices are written as  MxxX  ,...,22  ,    111 ,...,  MxxX
 . 
Similarly error matrices are;  ME   ,...,22  ,  111 ,...,  ME 
 . Each column of error and 
state matrices corresponds to the vectors at thk time step;  TkNkk xxx ,...,1
  ,   TkNkk  ,...,1
 . 
Input matrix is represented as;  MuuU ,...,1 . Parameters are also represented in a matrix 
form;   N NijA a IR                
 
Inputs are assumed to remain same for each time step. Equation (3.5) can be rewritten as 
follows; 
 
















































                   (3.6) 
 
This model can be further extended for a P  parallel experiment case as follows; 
 
  
                 
    
           
     
     
     
   
 































































































































  (3.7) 
 
One can write this equation in a compact form.  
 1122 EXAEX               (3.8) 
If the error terms are ignored the least square estimation for this equation can be written 
as; 
 
       TT XXXXA 21
1
11






Total Least Squares  
Total least square estimation for this system is shown for 
thi  dependent variable for all 
data points and experiments as follows;  
                 
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     
     
     
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   (3.10) 
          
In this equation first term refers to the thi   row of the  2X  and second term is the 
thi row 
of the 2E  . The first term at the right side of the equation is the 
thi  row of the parameter 
matrix A . 
This equation  is rearranged as follows; 
    
           
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 
       
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      (3.11) 
One can write this equation in a compact form as;  
    0111  CCba NiNi Nifor ,..,1                                                    (3.12) 





C Subject to Equation (3.12) 





       TTTLS XXIXXA 21
12
11
ˆ            (3.13) 
Where   is the smallest singular value of C . Compared to least squares, the TLS 
solution has a correction term, 2 , in the inverse term. This reduces the bias in the 
solution that is caused by noise in the independent variables. 
 
Constrained Total Least Squares method 
Least squares solution is not optimal when there is noise in independent variables. Total 
least squares takes into account the noise term in the independent variables. However it is 
not the best approach when the noise term is correlated, which is the case in this 
formulation. Kim et al [64]  proposed a CTLS framework that considers correlation in the 
noise term. Their method based on estimating parameters for each dependent variable one 
at a time similar to the TLS methodology. However noise terms in the independent 
variables are correlated as a function of all the rows of parameter matrix rather than each 
row. In our formulation we address this problem and reformulated CTLS framework for 
this model.  
To do that we started with rewriting equation (3.5) as follows;  
             (3.14) 
Here   ik e2  is the 
thi column of matrix,   2E
k  and it stands for error term for all dependent 
variables for all time points at the thk experiment. Similarly 
   ik e1  and 
   ik x1  are the 
thi  
columns of matrices,   1E
k  and  
2X
k  respectively.  
One can write equation (3.14) for 1i and 2i as follows; 
                                                                                                                (3.15) 
  (3.16) 
                    1,..,11122  MiforuxeAxe ikikikikik
                    111111212 uxeAxe kkkkk 





The thi column of  
2E
k is identical to the  thi 1 column of the matrix,  
1E
k . Therefore, 
one can write;  
  (3.17) 
If this is plugged in equation (3.16), it becomes;  
  (3.18) 
Equation (3.15)  and  (3.18) will yield the following expression; 
  (3.19) 
Similar to equation (3.17) thi column of   2X
k is identical to the   thi 1 column of the 
matrix,   1X
k . 
  (3.20) 
Plugging equation (3.20) in equation (3.19) and doing necessary cancellations will lead to 
the following; 
  (3.21) 
We assume that input stays constant throughout time for each experiment; 
   1uk =    2uk =…=    1Mk u =  uk                                                                            (3.22) 
Equation (3.21) can be rearranged as;  
  (3.23) 
One can write this equation for all 1M  columns; 
  (3.24) 
Sum of squared error terms for all time points and experiments are represented as 
follows;  
             (3.25) 
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  (3.26) 
TotalE  is a function of error and state at initial time step for all experiments, as well as 
input and measurements. Constrained total least squares is simply unconstrained 
minimization of TotalE . In this optimization problem decision variables are A ,
 uk ,and 
   1
1e
k  ; input variables are    11x
k  and  
2X
k . In other words, optimization should search for 
parameter space ( A ,  uk ) that will minimize the equation (3.26).  
  (3.27) 
We approached this problem in a step wise manner. The first step searches for 
matrix A  that minimizes TotalE  with respect to error at initial time step, 
   1
1e
k . This is 
represented as; 
  (3.28) 
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Least squares solution from equation (3.9) is given as initial condition to this 
minimization problem. Calculating the above equation will give the following set of 




  (3.29) 
In the second step of minimization problem, the resulting value for the term 
    Tk e 11 from the first step will be used. This step searches for parameters that will 
minimize TotalE  with respect to 
 uk . This is simply the solution for the following 
equation; 
 













E                                                                                       (3.30) 
After several matrix calculus steps this equation will lead to following set of expressions 
(see Appendix for details) ;  
 
 
  (3.31) 
 
In the case of multiplicative and additive noise in measurement are represented as 
in equation (3.2). CTLS framework can be modified to take into account of the nature of 
the noise terms.  
         vxbe jikjik           1,0Nu
k
i                
2,0 v
k
i Nv                  
(3.32) 
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In the above equation,    ji
k e  refers to the error for thi state measurement at thj time point 
of the thk experiment. Similarly, 
   j
i
k x  is the value of thi state at thj time points for the 
thk  experiment.  The term   is assumed to have a normal distribution. b  is a constant 
that accounts for the ratio of variance of the error to the signal. One can redefine the noise 
term  in equation (3.32) as follows;  
          2,0 vjikjik xbNe                                 (3.33) 
Equation (3.25) can be modified to integrate the noise model in equation (3.33). This is 
achieved by calculating sum of squared of weighted errors. With the new noise model, 
equation (3.25) becomes;  
 
             (3.34) 
In this expression, weight matrix    ik W  is defined as follows;  
           121 Nxv
NxjkNxNik IxbIW 

          (3.35) 
where,    jk x

 is the state vector of size N at the thj time point for the thk experiment.  
Minimization for the modified term can be calculated similar to the equations 




  (3.36) 
 
Similarly equation (3.30) can be modified to include weights;  
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We applied our algorithm on network models that are presented by Kim et al. Their first 
example network is a four gene network modeled by nonlinear differential equations. The 
model is shown figure (3.1) 
 
  

























































































































                   (3.38) 
In this set of equations  tx3  is the rate of change for the expression of thi gene at time t . 
SV  and K  and  values correspond to maximum enzyme rates and Michaelis constants 
respectively.  Parameter values for this model are given as follows; 51 
SV  , 
5.32 
SV , 33 
SV , 44 
SV , 2001 dV , 5002 dV , 1503 dV , 5004 dV , 6.114 aK ,
6.124 aK , 5.132 aK , 15.043 aK , 5.012 iK , 7.031 iK , 301 dK , 602 dK , 103 dK ,
504 dK , 414 A , 424 A , 532 A , 243 A , 112 n , 224 n  , 131 n , 232 n , 243 n . In 
                  111112  HZXEDU TkkTkTk


































this model the levels of perturbation for SiV are 100% from their nominal values. The 
measurement noise is assumed to be zero-mean white Gaussian with variance equal to the 
square of the equilibrium 0.02. Equilibrium state values are given as follows; 
4920.01 
eqx , 6052.02 
eqx  , 1866.03 
eqx  , 6514.04 
eqx  [64]. Drift noise case is also 
considered for this model. The details of this noise model can be found in [64]. There are 
four parallel experiments and in each experiment one of the four SiV values are perturbed 
in negative direction. Within each experiment, measurements are taken at a rate of (36s) 
for a number of time points varying from 3 to 60.  
The second network example is the feedback interactions between the tumor 
suppressor 53p  and the oncogene 2mdm . Feedback mechanism causes oscillations in the 
systems that vary from cell to cell. This model has been received attention in the recent 
literature.  The underlying nonlinear ordinary differential equation for this system is 
given as [64]; 




























                              (3.39) 
The level of perturbation on 53p  is negative 10% and the measurement sampling time is 
2 hours and white noise is added to the measurements.  






































The nonlinear models are perturbed at the equilibrium values to obtain a linear ordinary 
differential equation.  
     tutxFtx                        (3.41) 
where, F is the Jacobian,  tu  is the input term at time t and  tx  is the vector for the 
rate of changes in the deviation of the expression levels of all four genes from their 
equilibrium values.  
The aim of regression methods is to estimate Jacobian matrix correctly under the 
uncertainty and noise in the data. Since the measurement data are taken at discrete time 
steps, the discrete time representation of the equation is employed. This is identical to the 
equation (3.8). 
 1122 EXAEX                                                                                                      (3.42) 
,where 21, XX  is the measurement of the deviation for all states, time steps and 
experiments. The open forms of these matrices are given in equation (3.11). 
A is estimated through different methods in discrete domain. Estimation for 






                        (3.43) 
,where T  is the sampling time. Another transformation from discrete to continuous 
domain is the bilinear transformation.  




F            (3.44) 
Jacobian gives a quantitative picture of the local structure of the networks, 





true Jacobian F  and estimated Jacobian F̂  can be calculated in different ways. We 
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      (3.45) 
 
where ijf̂  and ijf  are the 
thi row and thj column elements for matrices F̂  and 
F respectively. 1N  and 2N  terms are the number of non-zero and zeros in true Jacobian 
matrix.  
The second error criterion is defined as follows; 











                                           (3.46) 
Where  asign is a function that has the sign of a  as its value,i.e.,-1,0,1 for 0a  
0a , and 0a , respectively. 
The third error definition is based on the Frobenius norm of the difference in true and 
estimated Jacobian matrices. 
FFF 
ˆ             (3.47) 
For first four-gene network example all methods are compared according to this 
three error criteria for different number of samples ranging from 6-30. The results are 
generated from 1000 Monte-Carlo simulations and they are tabulated in table 3.1.As it 
can be seen for small numbers of data TLS method has larger error compared to LS. This 
is due to the minimum requirement of data for TLS. Here CTLS-1 refers to the 





CTLS is represented as CTLS-2. We outperformed all regression methods as well as 
CTLS-1 consistently. Our method reduced M  error by an average of 21% and it  
improved F  by an average of 12% compared to CTLS-1. Compared to CTLS-1 we 
observed an average reduction of 21% and 27% for the standard deviation of M  and F  
errors respectively. For M  all methods give a similar level of performance. It can be 
observed that the accuracy of the estimation increases with increasing data points. 





           M               S               F  




LS 16.44 5.25 0.59 0.14 70.92 18.48 
TLS 79.93 333.79 0.74 0.19 580.46 2453.05 
CTLS-1 15.98 6.94 0.64 0.16 69.89 28.22 





           M               S               F  




LS 7.75 2.53 0.46 0.10 36.00 9.46 
TLS 11.56 9.59 0.54 0.14 64.76 80.98 
CTLS-1 6.58 2.88 0.47 0.11 32.16 13.16 





           M               S               F  




LS 5.15 1.65 0.40 0.06 24.91 6.62 
TLS 6.20 2.43 0.45 0.09 31.98 15.03 
CTLS-1 3.75 1.47 0.40 0.05 19.62 7.04 





           M               S               F  
Mean STD Mean STD Mean STD 
 
         
        21 
LS 3.64 1.04 0.38 0.02 17.87 4.27 
TLS 3.61 1.34 0.38 0.02 20.29 8.64 
CTLS-1 2.16 0.68 0.38 0.02 11.31 2.98 





           M               S               F  
Mean STD Mean STD Mean STD 
 
         
        30 
LS 3.70 0.90 0.42 0.06 17.31 3.74 
TLS 3.47 1.27 0.44 0.07 18.82 7.46 
CTLS-1 2.27 0.57 0.49 0.03 10.01 2.00 






To evaluate to drift noise effect we used the drift noise model in [64]. For different 
strength of drift noise the results for 1000 Monte Carlo simulations are shown in table 
3.2. Our method consistently outperforms all methods for all levels of drift noise. 
 





           M               S               F  
Mean STD Mean STD Mean STD 
 
         
        2.0 
LS 8.91 3.50 0.48 0.11 40.61 14.60 
TLS 32.97 190.54 0.59 0.16 244.44 2341.86 
CTLS-1 8.20 4.18 0.52 0.13 40.40 22.61 





           M               S               F  
Mean STD Mean STD Mean STD 
 
         
        1.0 
LS 6.18 2.07 0.43 0.08 29.17 8.58 
TLS 8.06 4.30 0.49 0.12 43.23 29.42 
CTLS-1 4.97 2.09 0.43 0.09 24.94 10.81 





           M               S               F  
Mean STD Mean STD Mean STD 
 
         
        0.1 
LS 5.20 1.62 0.40 0.06 25.18 6.69 
TLS 6.30 2.36 0.45 0.09 33.18 16.51 
CTLS-1 3.80 1.52 0.40 0.06 19.54 7.11 
CTLS-2 3.34 1.10 0.40 0.06 14.62 4.47 
 
In the second example with 2-gene network, our reformulation generally shows better 
performance compared to other regression methods. In this example, there are 4 
experiments and the number of samples for each example is varied 8-16. The results are 















           M               S               F  
Mean STD Mean STD Mean STD 
 
         
        8 
LS 0.82 0.16 0.50 0.00 0.03 0.01 
TLS 15.49 51.01 1.03 0.16 0.66 2.26 
CTLS-1 0.40 0.07 0.50 0.00 0.02 0.00 





           M               S               F  
Mean STD Mean STD Mean STD 
 
         
        12 
LS 0.50 0.05 0.50 0.00 0.02 0.00 
TLS 15.01 23.02 1.01 0.24 0.94 1.47 
CTLS-1 0.56 0.19 0.54 0.13 0.02 0.01 





           M               S               F  
Mean STD Mean STD Mean STD 
 
         
       16 
LS 0.45 0.04 0.50 0.00 0.02 0.00 
TLS 13.22 30.86 1.02 0.21 1.11 2.55 
CTLS-1 0.52 0.17 0.53 0.11 0.02 0.00 
CTLS-2 0.45 0.04 0.53 0.11 0.02 0.00 
 
3.5 Conclusions 
In this chapter we addressed the problem of network identification from noisy 
measurements. It is known that biological data has significant levels of noise. In 
regression from dynamic data the resulting estimation model has noise term in both 
dependent and independent variable. TLS is capable of taking error in independent  
variables into account. CTLS is a further improvement on TLS that can incorporate the 
correlation in the noise.  
We demonstrated superior performance of our novel CTLS framework on both 
existing one and other estimation methods on examples under the wide range of data 
points and noise levels.  
Though CTLS methods seem to improve parameter estimation significantly over 
the existing methods, the error levels are still high despite reasonable noise levels. 





experimental design to obtain high accuracy parameter estimation. In next chapter we 























































In the previous chapter we demonstrated the superior prediction power of our CTLS over 
various regression methods when there is no connectivity information is available. 
Connectivity data can be available from various sources such as protein-DNA binding 
data, protein interaction network databases and literature mining data. However this data 
can have high noise levels, inconsistencies or missing information. Time series 
microarray data is also corrupted by noise. It is essential to incorporate connectivity and 
time-series data to reverse engineer biological regulatory networks. The Bayesian 
framework is a powerful technique when there is connectivity and time series information 
with different levels of noise.  In this chapter we introduced a novel Bayesian parameter 
estimation framework that is capable of incorporating noisy topology and time series 
data. We demonstrated our framework on artificial network examples with a varying 
level of noise and number of data points.  
 
4.2 Introduction 
With the advent of various types of genomics data, there is an increasing necessity for 
computational regulatory network inference models that can serve to integrate diverse 
data. In this regard, Sabatti and James [37] introduced a Bayesian estimation framework 





genes along with TF protein levels at different time points using sequence and time-
course micro-array data. In [38], similarly, the authors sought to estimate protein levels 
and regulatory strengths; however, they reached the dynamical model by considering the 
transcription process as a set of biochemical reactions. In both studies, the nodes of the 
gene network are the gene expression levels and TF protein levels. TF protein levels are 
unknown (hidden variables ) and expression levels are the variables observed through 
micro-array data. Binding or sequence data provide topology (positions of linkages) in 
the network. As genomic data is scarce and noisy, estimating TF protein levels in 
addition to regulatory strengths may lead to poor reconstruction accuracy. TF protein 
levels as hidden variables will provide additional information on networks, but comes at 
the cost of higher quality and quantity of data. To this end, we concentrated on gene-to-
gene connectivity and regulatory strength estimation by combined use of binding and 
time-series micro-array data.  We introduce an algorithm that uses connectivity and time-
course gene expression data from micro-arrays. Binding data offers an initial topology for 
the networks, but they do come with significant errors giving false positives and false 
negatives in the network connectivity. Expression data also includes significant levels of 
experimental noise. The key to tackle these problems is that the inaccuracies are less 
likely when the algorithms focus on the agreement of both types of data. Bernard et al. 
[39] used both types of data in the context of dynamics Bayesian networks where binding 
data serves as the prior for the network topology. DBN is a directed graph model for 
representing probabilistic independence relation between multiple interaction entities 
using dynamic data on Bayes rule.  In their DBN approach, gene expression levels are 





posteriori distribution on the graphical structure (topology)  is sought by utilizing time-
course gene expression data. Unlike DBN method, we employ a Bayesian estimation 
model on which a posteriori distributions of model parameters are obtained.  By doing 
this, we mainly focus on distributions of regulatory strengths between TF genes and 
target genes.  We believe Bayesian estimation is a suitable framework to account for 
incorporating diverse types of noisy data and any prior knowledge. A deterministic linear 
model should be capable of revealing useful insights into larger-size networks.  
 
4.3 Problem Formulation 
 
In this section, incorporation connectivity data, micro-array time series data to the 
Bayesian framework and related probabilistic models will be explained in detail. Figure  
(4.1) depicts the pictorial representation of our approach. 
 
 
Figure 4.1: Pictorial representation of our reconstruction framework 
 
DNA-protein binding data is the direct information available to understand the regulators 
involved in transcription. It provides evidence as to whether a regulatory relationship 
exists through quantification binding of TF protein on DNA. This quantification is 
achieved through the use of p-test. The binding between a TF and a gene that gives p-test 





network with the nodes TF proteins and genes, this corresponds to presence of an edge 
between the TF and the gene. In [37] and [38], binding data is utilized as the binary 
connectivity matrix in TF Protein-gene network graph. Therefore, the p-value that is 
below the threshold is associated with the TF-gene pair having an entry 1 in the binary 
connectivity matrix. Otherwise, it is equal to zero. In our approach, we employ the 
similar concept of binary connectivity matrix to incorporate any connectivity data. 
However, instead of TF-gene connectivity, we assumed gene-to-gene connectivity. 
Therefore, the binding between a TF and a gene is interpreted as the connectivity 
between the gene that is producing the TF of interest and the gene being bound by TF 
(target gene).  In [39], protein-DNA binding data is adopted as gene-to-gene connectivity 
and formulated as an informative prior in Dynamic Bayesian network setting. However, 
instead of binary connectivity data, they map the p-values to a probabilistic model 
defining the probability of connectivity between the corresponding gene pairs.  
 
Protein-DNA binding data involves high level of false positives. False positives 
can be due to two kinds of error. A significant binding observation does not necessarily 
indicate a regulation relationship. Secondly, noise in observation and threshold selection 
impose false positives and false negatives. In our model, we adopted a corresponding 
probabilistic model to account for the error between true binary connectivity and 
observed binary connectivity which is obtained through binding data. In figure 7, we 









Figure 4.2: Illustration of true binary connectivity and observed binary connectivity  
 
Note that true binary connectivity is not known and one of the aims of reconstruction 
algorithms is to reveal true connectivity. The discrepancy between true binary,  ijrR    
and observed binary connectivity,  ijwW  , is modeled according to the following 
equations; 
  prwp ijij  1|1                 prwp ijij  11|0  
  qrwp ijij  0|0                            qrwp ijij  10|1 ,                                  (4.1) 
 
where p and q   are true positive and true negative rates respectively.  
 
Time-series micro-array expression experiments are a complementary source of 
data, which provides dynamic information about the expressions of thousands of genes 
that are activated or repressed in response to external stimuli [41]. Compared to steady-
state data, time series is more appropriate for understanding the dynamics of biological 
processes. 
Let Ntx    be a vector of expression levels observed in a micro-array 
experiment at time point, t . Expression levels for all time points can be written in a 





 MtMN xxxD ,...,,...,1 ,                               (4.2) 
  
An extensive list of studies on gene regulatory network modeling, using time-
series data, have focused on the continuous-time representation via differential equations. 
In our study, we also adopted a differential equation model for gene regulation.In this 
model, the expression level of a gene is assumed to be the concentration of its transcript. 
The rate of change in the concentration of a particular transcript ix  is given by a function 
if   whose arguments are concentrations of other RNA species and parameters; 
   iNii xxftx ,,...,1              Ni ,...,1 ,                                              (4.3) 
 
 
where N  is the number of transcripts in the network. In general, only a small subset of 
all RNA species participates in the regulation of a particular transcript. In other words, 
the networks are sparse [2]. Different forms for if   can be adopted. We adopted a linear 
form for if , and discrete form of equation ( 4.3 ).  The model becomes as follows; 







1 ,                                                                                          (4.4) 
where ( )ix t  expression level of 
thi gene, and ija  is the regulatory strength between 
thi  and 
thj  genes. A positive value for ija  indicates activation of 
thj  gene expression by gene i, a 
negative values corresponds to inhibition of expression level of thj   gene by thi , and a 
zero value shows that there is no regulatory relationship between thi and thj genes. The 
model can be written for all expression levels.  





In equation (4.5),   Ntx   is a column vector of expression levels of N  genes 
at time point, t  , and  ijNN aA   is the regulatory strength matrix. For all time points, 
equation (4.5) becomes; 
AXX   ,          
    1,..,1  MxxX          MxxX ,..,2           1,  MNXX                                 (4.6) 
where X and X  are obtained from micro-array data matrix,  MtMN xxxD ,...,,..,1  
given in  equation (4.2). M  is the number of time points. (The number of micro-array 
experiments).  
All data that is obtained from true model placed into a Bayesian estimation 
framework with appropriate probabilistic models.  We seek to infer the posterior 
distribution for the parameters (elements of activity matrix),   NNijaA  . Doing this 
we are trying to recover the presence, strength and nature of the linkages among the 
nodes in true network. Using the Bayes rule, the posterior distribution over the activity 
matrix, A  can be represented as follows; 
 








 ,                    (4.7) 
                                             
 
where  WDA ,|Pr  is the posterior distribution on regulatory strength matrix given 
micro-array data, D  and observed binary connectivity, W .  WA |Pr  is the prior on 
regulatory matrix, A  given the observed binary connectivity.  WAD ,|Pr  is the 
likelihood of the micro-array data given the regulatory strength matrix, A .  In the next 






The prior term,  WA |Pr  is decomposed as follows;  
     WRRAWA |Pr|Pr|Pr  ,                                                                                    (4.8) 
where  
ijrR   is the unknown true binary connectivity introduced in the Bayesian 
framework.  WR |Pr  is simply the error model between true and observed connectivity 
matrix which is given in equation (4.1). The model can be rewritten in matrix form as 
follows; 















,                             (4.9)   
where p  and q  are the rates of true positives and false negatives respectively. It is 
assumed that error for each pairs of genes are independently distributed.  RA |Pr , on the 
hand, is the probability of regulatory strengths given the binary connectivity matrix. It 
models the regulatory strength in each pair of genes, ija , given the presence or absence of 
a connection between them.  The term, ija , is assumed to have a Gaussian distribution 
















































ra ,                 (4.10) 
 
One can write the probability,  1|Pr ijij ra  as follows;  
                             




















































ijij ra |Pr  is assumed to be independent for each pair of genes, then we obtain the 
following expression;  
 



















































                            (4.12) 
 
Using equations (4.9-12), equation (4.8) is rewritten as follows; 
   





































































      (4.13) 
 
The likelihood term in Bayesian formula,  AD |Pr  has Gaussian distribution 
with zero mean according to the linear discrete time model given in equation (4.6). The 
corresponding probabilistic model is given as follows; 












































,             (4.14) 
 
The final form for the Bayesian framework is written as follows and contains the 
unknown true connectivity matrix, R  ; 

























































































































    (4.15) 
 
Solution methodology 
To solve the complicated expression of equation (4.15), a Gibbs Sampler approach is 
employed which samples each component, A  and R  at a time while fixing the other 
components. As maximum a posteriori network is sought, the formulation is modified 
accordingly. In the first step of each iteration, the binary connectivity matrix is held fixed 
and maximum a posterior estimation on A  is calculated according to the following 
formula; 
      RAXXARDA AA |Pr,|Prmaxarg,|Prmaxarg                      (4.16) 
One can take the natural log of the right hand side of equation (4.16) and drop the 
minus sign. The equation becomes as follows; 
 
















































































                             (4.17) 
Equation (4.17) is nothing but regularized least squares solution with weights 






In each iteration, the second step is the maximum a posteriori estimation of binary 
connectivity matrix, R  when regulatory matrix, A  is held fixed at its value calculated in 
the previous step.  
     arg max Pr( | , ) arg max | |     R RR W A P A R P R W     
 














































































































To evaluate the performance of the algorithm, we created an ensemble of 100 artificial 
networks. A linear discrete time equation model is assumed for the created networks. 
(See equation (4.4)). In each network, all genes are perturbed randomly, and while the 
system is reaching to a new steady state, measurements are taken for all genes at certain 
time points. We introduced false positive and negative error on the topology to simulate 
noisy prior connectivity data. Furthermore, measurement noise is added to the data with 








Figure 4.3 Illustration of data collection and simulating topological and measurement 
errors.  
 
The prediction power of the method is calculated through two performance 
metrics. The first one is defined as the fraction of the eliminated topological errors. It is 
represented as follows;  
 
    
(4.19) 
 
In equation (4.19),  
ijrR   is the true connectivity matrix,  ijwW   is the initial 
observed topology and  ijwW   is the estimated topology. This is represented as 
follows; 
 




































where ijâ  is the estimated regulatory strength. If it is greater than a certain threshold,   
then the estimated connection between thi  and thj  gene is equal to 1, otherwise it is zero.  
The second performance metrics is the relative error in parameters. This is defined as the 
Frobenius norm of the relative difference between calculated and true parameter matrices.  
 
                                                      (4.21) 
 
The average percentage errors for the ensemble of 100 randomly created artificial 
networks are calculated and plotted against different number of measurements. Each 
network has 10 genes and 30 connections. For each network, topological error is 
introduced as follows; There are total of 12 errors. 3 random connections are deleted 
(false negatives) and 9 false connections (false positives) are added. The multiplicative 
error variance in samples is changed in the range of 5-20% of the signal. In each 
experiment, 8 time points are sampled and the number of experiments changed from 1-6. 











































Figure 4.4 Fraction of eliminated topological error for different levels of measurement 













It can be seen from figure (4.4)  that  as number of data points is increased the 
fraction of topological error that is eliminated increases. Furthermore, the prediction 
power decreases with the increasing noise levels, which is expected. For example, in 20% 
noise case, 6 parallel experiments with 6 time points in each are required to eliminate 
80% percent of the topological errors.   
In the next step of analysis, we looked into the performance in estimating the 
value of parameters. This is done by plotting the relative error in parameters with respect 
to the number of data and varying multiplicative noise levels.  
. 























Figure 4.5: Relative error with respect to various number of data points.  
As it is seen from figure (4.5), relative error decreases with increasing number of data. 
Furthermore prediction power decreases with the increasing noise level. For 20% noise 
case, the relative error is approximately equal to 1 for 6 parallel experiments and 6 data 
point in each experiment. Though 80% of topological errors are eliminated for this case ( 
see figure 4.4), relative error in parameters is 1.  
In the second part of analysis total number of topological error is fixed at 12 





increased the number of false positive errors. As it can be seen from figure 4.6 the 
performance of eliminating topological error has significantly decreased even though 
number of error remain constant at 12. Relative error in parameters stayed high and 
didn‟t change significantly. 








































Figure 4.6  Fraction of eliminated error with 15% measurements error for two different 
cases of topological errors. The curve with lower error elimination rate has 9 false 
negatives and 3 false positives. The curve with higher error elimination rate has 3 false 
negatives and 9 false positives. 
 




















15% error, 9FN, 3FP
15% error, 3FN, 9FP
 
Figure 4.7 Relative error with 15% measurements error for two different cases of 
topological errors. The curve with lower error elimination rate has 9 false negatives and 3 











Binding data provides an initial topology of the gene networks. However, this data 
suffers from high rate of false positive and negative errors. In these results, we see that 
our algorithm is able to fuse connectivity data and micro-array data and to approach true 
network topology and dynamics provided that enough data is available.  However, for 
reasonable levels of noise in the data (10-20% multiplicative noise) the error in 
parameters is still quite high. This raises the issues of additional prior information 
requirement and optimal experimental design. Furthermore, better error models for both 
micro-array and binding data may significantly decrease the data requirements. The 
major problem in topology data is the false negatives, in other words, missing links in the 
prior topology. It is important to be able to identify missing links in the prior information. 
To this end in next chapter we concentrated on link prediction techniques using 
network‟s topological distribution data. We introduced a novel link prediction method 


















LINK PREDICTION THROUGH NETWORK CONNECTIVITY USING 






In the previous chapter we introduced a Bayesian method that integrates connectivity and 
time series data. We concluded that in order to utilize the network identification methods 
to their full extent more accurate prior connectivity data is needed. The major problem in 
identifying connectivity is false negatives, in other words, missing links in the network. 
In this chapter we focus on identifying missing links based on existing connectivity 
information. We demonstrate finding missing links in protein target identification using 
literature mining data. Target identification is very crucial in pharmaceutical research.  
The pharmaceutical industry frequently brings a new promising target to clinical trials 
only to find that it has serious safety concerns or lack of efficacy.  A gene downstream or 
upstream in the targeted pathway can serve as a remedy, however, finding such an 
alternative target using existing in-silico or bench tools can be extremely labor-intensive. 
Recently, increasing amounts of information and observations have been compiled from 
different areas of biological research and deposited on databases.  In this work we 
propose a novel computational method to quantify indirect relationships between the 
objects of biological research of interest by using existing relationships from text mining 
databases to automate the search for novel biological targets. We apply our method to 
analyze 10850 proteins in Ariadne database and created a rank-ordered list of protein 





effort of identifying novel targets that are most similar to the existing unsafe or inefficient 
targets.  We compared the prediction power of our method with the Jaccard and Common 
Neighbors similarity scores. Our method outperformed both methods in predicting the 




Biological processes are the result of interactions involving hundreds of thousands of 
molecular entities. These interactions form complex networks. In a biological network a 
node represents a biological entity and a link refers to association between two biological 
entities. This association can be a physical link, a functional similarity or an implicit 
relation. It is becoming increasingly important to approach biological problems from a 
perspective of networks and identify missing links in the network. To understand diseases 
and find new drug targets in a systematic way, it is critical to scrutinize the topology of 
these networks. 
Link prediction methods in complex networks have attracted increasing attention 
from computer scientists and physicists [57-60]. These methods usually aim at estimating 
likelihood of the existence of a link between two nodes based on observed links and the 
attributes on the nodes [61]. Link prediction methods can be classified into two 
categories; the first is prediction of existing but unknown links; the second is prediction 
of future links. Biological link prediction falls into the first category [49]. Discovery of 
links in biological networks can be costly and time consuming through experimental 
means.  Making predictions based on the existing links instead of blindly checking all 
links can considerably reduce the cost, both in time and money. Furthermore, missing 





missing links can be potentially used as a tool to improve connectivity information for 
reverse engineering of networks. There are many biological applications of link 
prediction methods. One of them is the target identification. A biological target may refer 
to a protein that has been intended to be a target of a drug.  
Drug-target interaction (interactions between drugs and target proteins) is a key 
area in drug discovery.  Both number of new drugs and targets hasn‟t changed 
significantly in the last 20-25 years [51].  In target identification problem a protein in the 
downstream or upstream of the network might be an alternative to an existing inefficient 
target, however, not all pathways are known, and finding such an alternative target using 
existing in-silico or bench tools can be extremely labor-intensive. A method that can 
automatically find implicit relationships between network nodes (proteins, diseases, 
drugs, compounds etc.) can be invaluable in the search of new target. There are many 
studies on target identification problem. Yamanishi et al [52] integrated known drug-
target information with target protein sequence data and drug chemical structure and 
proposed as a new target-identification tool. In another study, Campillos et al [53] used 
side effect similarity between drugs to predict novel targets for drugs. They based their 
method on the assumption that the drugs that share common side effects are more likely 
to share targets. They combined drug-target, drug-side effect information with drug 
chemical similarity. They also validated some of their predictions with experimental 
results. These studies are based on finding target space for existing drugs. In this study 
we try to find novel targets that are most similar to existing targets based on its 
connectivity in networks that are obtained from literature mining databases. Increasing 





automated way of collecting the relationships between biological entities through co-
occurrences within electronically available records [61]. Text mining aims at collecting 
and retrieving useful hidden relations from these resources of information. Therefore, text 
mining databases represent different sets of pre-compiled information on biological 
relationships and associations, interactions and facts which have been extracted from the 
biomedical literature. 
  In this chapter we propose a novel computational method of drug target discovery 
by quantifying indirect relationships between the nodes of biological networks using 
interactions retrieved from mining databases. This method can also be used to annotate 
diseases with similar etiology, reposition existing drugs, or discover adverse events for 




Our model is based on a computational approach that quantifies the relevance of two 
biological objects such as genes, proteins, compounds, complexes, drugs, diseases 
(hereafter referred to simply as “objects” or “entities”)  by comparing their common 
connections, obtained through databases against a random network model obtained 
through the databases. Denoting an object of interest with „ A ‟, one can identify other 






Figure 5.1. Random bipartite network model for entities A  and B  
 
The text mining database information can be represented as a directed bi-partite 
network. In graph theory a bipartite graph is graph whose vertices can be divided into two 
sets. This is a directed graph where the relations between the nodes are represented as 
arrows with originating from a source node and ending in a sink node. Out-degree of a 
source node in a directed graph is the number of edges (arrows) originating from the node 
and in-degree of a sink node is the number of arrows ending in a sink node. In other 
words an out-degree is the number of distinct objects that a source node (first set object) 
is effecting and in-degree is the number of distinct objects a sink node ( second set 
object) is being effected by a source node(first set object). Figure (5.1) is a directed bi-
partite graph model where the random network model is sought using the parameters of 
the network. It consists of two sets of nodes. The first set nodes are the source nodes A  
and B and the second set nodes are the sink nodes 71,...,CC . Each node in both sets refers 
to certain biological object. The parameters are the out-degrees of the pair of the entities 
A  and B  and in-degrees of objects in the second set along with the number of entities in 
this set. Out-degrees of A  and B  are represented with 
1N  and 2N , whereas in-degrees are 





partite graph.  Let us denote the parameter set that we obtain from the database 
with,  SxxxNN S ,,..,,,, 2121 .  
Random graph construction is a method to model the possible ways for A  and B  
to connect to the objects of the second set. This allows us to quantify the likelihood of A  
and B  having common downstream objects when drawn from a random graph.  We 
compare the observed common downstream connections in the database against this 
random graph model to quantify the similarity between A , and B . If A  and B  in the 
database graph share substantially more downstream connections than would be predicted 
by a purely random graph, then we have evidence to suggest that they are similar.  
Let us define the two different events on this bi-partite graph. The first event is 
the number of common entities to which  A  and B  are connected and the second event is 
the set of in-degrees of these common entities.  The joint probability of these two events 
can be represented with following expression; 
 
   |,,...,, 21 kimmmMP k                                            (5.1) 
          
,where M  is the list of the in-degrees of the common downstream entities, and i is the 
number of common entities.  Using the definition of joint probability distribution, one 
can write the following equation;  
    (5.2) 
                                                                                                   
In this equation   |kiP   is the probability of first event given the parameters, and 
  ,|,...,1 kixxMP k   is the conditional probability of second event conditional on the 
first event given the parameters.  





The first term in this equation,  |kiP   can be derived as a function of the 
parameters; 
1N , 2N  and S . In figure (5.2), a random configuration of bipartite graph for 
A  and B  is shown. Connections that are common for the pair are represented with solid, 
whereas node specific connections are displayed by dashed lines.  
 
 
Figure 5.2. Example of A  and B  having common second set entities, 
2C , 3C . 
 
In order to derive the probabilistic distribution for the number of common objects 
that A  and B  share, we start with enumeration of different possibilities. The number of 
combinations of the 1N  connections that A   can make with S  different second set 












                         (5.3) 
                      












              (5.4) 
 
Let L  denotes the total number of combinations of A   and B  connections to any 
1N  and 






   













                                                              (5.5) 
                     
The number of combinations for A  and B  having k  common downstream objects 









                                                                                       (5.6) 
 
 
Once k  connections of A  and B  are fixed, they have  kN 1  and  kN 2  connections 
remaining respectively. The number of objects available in the second set is reduced 
to  kS  . The number of ways that the remaining connections of A  could be chosen out 
of  kS   entities can be calculated as follows;  
    
 










                                                                                (5.7) 
 
 
This will fix the number of all 
1N  connections of A  and there will be  1NS   objects left 
for  kN 2  remaining connections of B . The number of combinations for remaining 
connections of B  for the remaining objects is represented as follows;  
    
 











                                                                (5.8) 
 
The overall number of combinations that A  and B  are connected to k  common objects 
will be the denoted with D . It can be written as;  
           
 
 
   
 































The probability that A  and B  are connected to k  common objects is the ratio of the total 
number of combinations of A  and B  are connected to k  objects in common to the total 
number of combinations that the pair is connected to objects in any possible way. This 
probability is written as;  
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   











































       (5.10)
    
 
 
After cancelations, we obtain;  
 
 
   










                                                       (5.11) 
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NN 21                 
   
(5.12)                                 
                                                                                           
 
,where   is  a function of   
1N , 2N  and S while   is the normalization factor. It 
normalizes the cumulative distribution to one at   21 ,min NNi   as the probability is not 
defined beyond this point. This approximation allows us to obtain a compact 
representation for the probability term. It is less computationally intensive. The aim is to 
derive a compact similarity score function between two objects that makes sense 
intuitively starting from a formal probabilistic framework. 
To check the validity of the approximation we calculated sum of absolute 





  21,min,...,1,0 NNi   at different values of 1N  and 2N  . This corresponds to the deviation 
of cumulative distributions for Poisson and equation (5.11). We defined the percentage 
deviation as follows;  
 
 
   














































      (5.13) 
 
In figure (3), we illustrated the calculation the value of E  on an example. The absolute 
deviation of Poisson approximation corresponds to the sum of lengths of the dotted lines.  
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Figure 5.3. Deviation of the model from Poisson distribution for 101 N , 252 N , 50S  
 
 
In figure (5.4), the curves for various E  values are shown at different values of 
1N  and 
2N . The area under each curve shows the region for the values of  1N  and 2N  where 
Poisson approximation exceeds the given percentage deviation. For example the 
deviation of Poisson approximation is less than 10%  when one of the objects has four or 
more connections ( 41 N ) and the other object connected to less than 34% of all second 





the curves remain same for different values of S  . This figure shows that Poisson 
distribution is a reasonably good approximation for a large span of 
1N  and 2N  values. 






















One can also derive the conditional probability term on the right hand side of equation 
(2). In figure (5.5), a possible connection pattern is shown for illustration purposes. k   is 
the number of shared entities between A  and B  (in this example there are two common 
entities) , M  shows the list of common entities and X is the set of in-degree values for 








Let us consider the general case for k  common objects. The number of possible 





a given in-degree of ix   is equal the number of 2-combinations of ix  . In other words, it 
is the number of combinations that two objects ( A  and B  ) can be connected to  a 









xCc                                                                                                        (5.14) 
  
 
In this equation the number of combinations where A and B are both connected thi object 
is denoted by ic .  
The number of possible connections of A  and B to any k  objects with known in-degrees 













...                             (5.15) 
 
In this equation there are k  embedded summation terms corresponding to k  common 
objects. Each common object can be chosen out of S  different objects. For large S , this 
summation term would be difficult to calculate. Therefore we introduce the following 
approximation.  
            
                       (5.16) 
 
Here we assume that all ic  terms are equal to an average ĉ  term. If (16) is plugged into 
expression (15), we obtain the following approximation,  
 
           
                       (5.17) 
 
One can represent the number possible ways that A  and B  are connected to k  particular 
objects as follows; 























                  (5.18) 
The probability that A - B  pair are connected to k  particular objects is calculated 
as the ratio of the number of combinations that this pair is connected to k  particular 
objects to the number of different ways that they are connected to  any k  objects.  
 
           
                                                        (5.19) 
 
 
Plugging expression (5.19) and (5.12) into expression (5.2), we obtain  
 
                                                                                                                                                                                                                 
                                                                                                                                      (5.20)                     
 
 
This equation gives us the probability of two entities having k  common 
downstream objects from the set M .  It is derived based on a random bi-partite network 
model using the parameter set,  . The similarity between the pair of entities; A  and B is 
assumed to be based on the statistical significance of their common connections 
according to the probability of occurrence in a random network model. To quantify the 
significance of an observed connectivity structure of the pair that has common 





                 (5.21) 
                                    
 
Hence, the lower the probability of occurrence for a random model is, the more 
significant the event is and therefore the higher the score. One can write score in an open 














































































             (5.22) 
      
One can use Sterling approximation for the term,  !log k ; 
    kkkk  log!log                          (5.23)                                                                                                                         
 
Using (5.23), expression for   in (5.12) and rearranging the terms, expression (5.22) can 
be rewritten as follows;   























loglog                  (5.24)  
 
This equation can be further simplified by the following assumption;   























loglog                (5.25) 
     
Finally, one can obtain the following expression;  
   
            
                                                        (5.26) 
 
 
This function gives us the similarity score between A  and B  based on the network 
structure and properties.  In this expression,  cS ˆlog 2  is a network domain-dependent 
constant. A network domain can be defined as part of the network with all biological 
interactions of a certain type. Examples of such domains can be transcriptional 
regulation, protein binding, protein modification and any other biological function that 
connects one biological entity to another. Each domain might have different number of 
second layer entities ( S ) and connectivity structure ( c ).   
One can see that the similarity score is directly proportional to number of 
common downstream objects, k . This is an expected result as one expects two entities to 















































proportional to both 
1N  and 2N .  This can be interpreted as the more connected the 
species are the more likely they have common downstream effect by chance. Finally, the 
score is inversely proportional to in-degree of the common objects connected to the pair.  
This is the result of the fact that the pair will more likely to have common downstream 
entities that have high in-degree by chance. Hence, this commonality gives relatively 
lower significance for the similarity.  
 
5.4 Results 
We applied our algorithm to the Ariadne database. Ariadne is aSystems Biology software 
that consists of computational methods to generate databases from the literature. Ariadne 
database represent different sets of biological relationships which have been extracted 
from the biomedical literature [63]. To test our algorithm we extracted 10850 proteins 
and approximately 200,000 protein-protein associations from Ariadne. Each association 
corresponds to a biological mechanism, such as; binding, regulation, activation, 
inhibition, modification, etc. These proteins are grouped into two. First group is the 
regulators and second group represents the regulatees. We applied our algorithm on each 
pairs of regulators. Note that our algorithm quantifies the relationship between two 
regulator proteins depending on the number of common regulates they share, in-degrees 
of these regulates as well as out-degree of the regulator proteins.(See equation 5.26).   A 
rank list of regulator protein pairs are created, starting from most similar regulator pairs 
going through the least similar ones. Some regulators are actually connected to each 
other. This constitutes the probe set. Probe set is not used in prediction algorithms and it 





prediction power on this probe set. To quantify the prediction accuracy we employed 
receiver operating characteristics (ROC) curve approach. ROC curve quantifies 
sensitivity and specificity of a prediction method in a systematic way and it is one of the 
standard methods to measure performance of prediction methods. In the decreasing-order 
rank list of protein pairs, a threshold value for the similarity score is chosen. The pairs 
with similarity score higher than the threshold value are taken as positives and the 
remaining pairs are the negatives. The positive set and negative set is compared to probe 
set to determine true and false positive rates.   
We compared our method with existing similarity index measures. Common 
Neighbors (CN) and Jaccard (J) methods are the most commonly used similarity scores in 
link prediction.  Common Neighbors method assumes that two nodes are more likely to 
form or have a link if they have many common neighbors. 
     yxCNScore            (2.14) 
Here,  x  is the set of nodes connected to node-x and similarly  y  is the set of 
neighbors for node-y .  
Jaccard is another quantification of similarity index between two nodes in a 
network. It is a function of out-degrees of the node pair as well as number of common 
neighbors they have.  
 
   





           (2.16) 
ROC curve comparison of the methods is given in figure (5.6). A roc curve plots true 
positive rate with respect to false positive rate. The area under the curve shows the 








































Figure 5.6. Receiver operating characteristics curve for Common Neighbors (CN), 
Jaccard (JAC) and our bipartite approach (BP). „Random‟ curve refers to prediction is 
made based on completely naïve random approach.  
 
It can be seen from figure (5.6) that our bipartite approach outperforms Jaccard and 
Common Neighbors methods on the protein-protein interaction network obtained from 
Ariadne database.  
5.5 Conclusions 
The contribution of this work can be summarized in two ways. First, our method is a 
novel computational algorithm to quantify indirect relationships between the objects of 
biological research of interest by using existing relationships from text mining databases 
to automate the search for novel drug targets. This method can also be used for different 
purposes such as; annotating diseases with similar aetiology, reposition of existing drugs, 
or discovering adverse events for the targets. Secondly, in a case study involving 9575 





































        CHAPTER 6 
 
COMPUTATIONAL ADVERSE EVENT PREDICTION THROUGH A 




We introduced a link prediction method in the last chapter and demonstrated its 
prediction power for protein-protein association networks obtained from literature mining 
databases. However, this method is applicable to the bipartite networks. In this chapter 
we will look into the link prediction methods for multipartite networks. One immediate 
application of this is the adverse event prediction.  
 
6.1 Summary  
Adverse event prediction is becoming increasingly important as health authorities focuses 
on the obligation of the pharmaceutical industry to ensure that marketed drugs have 
acceptable benefit-risk profiles. Therefore, it is critical for pharmaceutical companies to 
identify potential toxicity risks of the drugs during early phases of the lengthy drug 
development process. To date the adverse event prediction methods are mostly 
concentrated on finding novel targets for the drugs as side effects may be due to the 
unintended targets of the drugs. Biological pathway knowledge is a crucial source of 
information that can help predict the side effect profiles of the drugs. Moreover, animal 
models can give clues on possible adverse events in the early phases of drug 
development. To the best of our knowledge there has been no systematic network based 
study for finding significant associations between biological pathways and side effects as 
well as mouse phenotypes and side effects. In this study we introduced a computational 





We integrated MGI, KEGG pathway, Drugbank and SIDER information on a multilevel 
network representation. A p-value based approach is introduced to find significant 
associations between pathway-side effect as well as mouse phenotype-side effect pairs. 
We demonstrated the biological relevance of these associations with two examples. 
Finally, we validated the prediction power of our method using ROC curves. 
 
6.2 Introduction  
 
An adverse event (side effect) is an unwanted response to a drug that has happened 
during treatment of patients or clinical trials.  Increasing scientific, regulatory research is 
focused on the obligation of the medical community, pharmaceutical industry and health 
authorities to ensure that marketed drugs have acceptable benefit-risk profiles. In that 
regard adverse event prediction methods for drugs become increasingly important.  
Drugs bind to target proteins and affect biological pathways, and these pathways 
cause phenotype effect. An adverse event can be caused by drugs known targets (target 
effect) or it can be due to proteins that are not yet identified as the targets of the drug (off 
target effects). Adverse events vary from simple symptoms, such as nausea, to critical 
symptoms, such as torsades de pointes. Most side effects are harmful to humans, but side 
effects can also be utilized to find new uses for known drugs. Therefore, it is highly 
desirable to automatically discover new targets for known drugs and to understand the 
mechanisms that cause side effects for target-specific treatments. There are several 
studies concentrated on finding drug targets integrating various information resources. 
Yamanishi et al [52] integrated known drug-target information with protein sequence 





al [53] utilized side effect similarity between drugs to predict novel targets for drugs. 
Their method based on the assumption that drugs that share common side effects are 
more likely to shared targets. They validated some of their predictions through 
experimental results.  
Yamanishi‟s and Campillos‟s studies were focused mostly on finding off-target 
proteins causing the side effects. However it is important to consider biological pathways 
that are affected by the drugs.  Proteins in the downstream of a drug‟s known targets can 
lead to side effects. The knowledge of a pathway allows separate targeting of upstream or 
downstream targets. Inhibition or modulation of selected targets in the same pathway 
could lead to the same therapeutic with fewer side effects or better druggability. 
Furthermore these targets can crosstalk with other pathways which may be potential 
sources of the observed side effects. Therefore the knowledge of pathways and their 
relation to each other helps researchers understand side effect profiles [71]. To the best of 
our knowledge there has been no systematic study of integrating pathway-target-side 
effect relationships on a network framework to find significant Target-Side Effect or 
Pathway-Side Effect relations.  
It is essential to identify adverse events in the early phases of drug development. 
Two of these early phases include target discovery and animal models. Animal models 
have specific characteristics that mimic human diseases. The technologies for the creation 
of transgenic animals, where certain genes are deleted, modulated, or added, have 
progressed tremendously in the last decade. As a result, the predictive power of animal 
models for human disease and pharmacology is improving. It is crucial to note that some 





believe that inadequate animal models, or the lack of animal models altogether, are a 
major obstacle in drug discovery and development. Pharmaceutical companies have long 
used model organisms in preclinical efficacy [71]. The laboratory mouse is the premier 
animal model for understanding the genetic and molecular basis of human biology and 
disease
 
[72].  Therefore, mice models can be a useful resource to understand potential 
side effect of the drugs. To date, there has been no networks based systematic study to 
understand Mouse Phenotype -Human Side Effect relationships.  
In next section we will list the data sources that we used in this research and give 
a brief background for each. We will also introduce the network based methods that we 
employed for finding significant links in resulting multilevel networks created by 
integration of these databases. In the results and discussion section we will validate our 
method through receiver operating characteristics (ROC) curves and point out major 
findings. Finally we will give most significant findings and future extensions of this work 




In this study we obtained drug-target relationships from Drugbank database [56]. This 
database provides detailed drug (i.e. chemical, pharmacological and pharmaceutical) data 
with comprehensive drug target (i.e. sequence, structure, and pathway) information. The 
database contains 6826 drug entries including 1431 FDA-approved small molecule drugs, 
133 FDA-approved biotech (protein/peptide) drugs, 83 nutraceuticals and 5211 






Drug-side effect relationships are obtained through SIDER database (Side Effect 
Resource) [53]. This data source is a collection of side effects for marketed drugs that are 
obtained through the drug package inserts[53]. It has 888 drugs and 1450 side effect 
terms associated with them.  
A valuable resource for biological pathways and target association is the KEGG 
pathway database (Kyoto Encyclopedia of Genes and Genome) [54]. This is a collection 
of manually drawn pathway maps representing the collected knowledge on the molecular 
interaction and reaction networks [54]. In this data source there are 203 distinct pathways 
associated with hundreds of protein targets.  
We combined SIDER databases with Drugbank to obtain target-drug-side effect 
relationships. To do that we matched SIDER drug names with Drugbank drug names and 
obtain 708 matching drugs out of 888 SIDER drugs. There are 653 distinct targets 
associated with 708 matching drugs. Furthermore, these 653 targets are matched in 
KEGG database to obtain pathway-target relationships. The integration of these databases 
forms a multipartite network that is shown in figure (6.1).  
 
Figure 6.1. Integration of KEGG, Drugbank and SIDER databases on a multilevel 






A valuable information resource that can be obtained from the MGI database is 
the mouse phenotype-mouse gene associations. The MGI database is a comprehensive 
information source that primarily provides genetic and genomic data to support 
laboratory mouse a model organism. [73] To achieve this goal, MGI maintains a 
comprehensive catalog of mouse genes and other genome features and associates these 
features with orthologous genes in other mammals, human diseases, functional 
annotation, mouse phenotype descriptions, DNA and protein sequence data and 
developmental gene expression information. We matched 429 mouse genes that are 
orthologues of 653 human targets. There are 3637 distinct mouse phenotypes 
corresponding to these 429 mouse genes. We combined MGI database with Drugbank 
and SIDER resources. In figure (6.2) all relationships from mouse phenotypes to human 
side effects are casted on a multipartite network frame. 
 
Figure 6.2 Integration of MGI, Drugbank and SIDER databases on a multilevel 
network.  
 
Our aim is to find significant target-side effect, pathway-side effect and mouse 





the next logical step is to introduce a random model. By doing this observed structures in 
the network can be scored based on the random model and those with higher scores will 
give the significant links. We employed a p-value based approach to find important links. 
Each level in this multilevel network is randomized as follows; the degree of the nodes 
(number of connection at each node) in each level is kept constant and edges are shuffled 
for a large number of times. This procedure is repeated for each level. By integrating the 
random networks for each level we obtained a random multilevel network at each 
iteration. The resulting ensemble of networks constitutes random multilevel network 
space. Using this random network space the next step is to create a p-value for each 
observed target-side effect, pathway-side effect and mouse phenotype-side effect pairs. 
We based p-value on the count of drugs connecting these each pairs. One can obtain the 
distribution for the number of drugs connecting each pair of association from the random 








kp                (6.1) 
In equation (6.1)  kpij  is the probability of observing k  drugs connecting the 
thi  target 
(or mouse phenotype, or pathway) with the thj  side effect. 
k
ijN  refers to the number of 
random networks that have k  drugs connecting the thi  target (or mouse phenotype, or 
pathway) with the thj  side effect. totalN  is the total number of random networks in the 
ensemble. A p-value for each pair of association can therefore be calculated as the 














ijij kp              (6.2) 
In this equation *k  is the number of observed drugs connecting the thi  target (or 
mouse phenotype, or pathway) with the thj  side effect. ij is the p-value for association 
between the thi  target (or mouse phenotype, or pathway) and the thj  side effect. 
In the next step of our analysis we aim at validating our method by predicting 
each drug‟s side effects through their known pathway information. We utilized receiver 
the operating characteristics curve (ROC). We employed leave-one-out validation 
method. In this method each drug left out one at a time while creating the random 
network space. Significant pathway-adverse event association pairs are obtained using 
this random model. These pairs are then ranked in an increasing order of p-value. A p-
value threshold is chosen and the pairs that have p-value lower than the threshold are 
chosen as significant pairs. From known targets of the drug that is left out one can find 
the related pathways. These pathways are matched in the significant pathway-adverse 
event pairs and the union of corresponding adverse events is the predicted adverse event 
set. Predicted adverse events are then compared with observed adverse events. Observed 
adverse events are the side effect list of the drug that is left out. Comparing predicted 
adverse events with observed ones gives false positive and false negative rates for the 
side effect prediction. By increasing the p-value threshold one can obtain ROC curves for 






Figure 6.3 Procedure for predicting side effect for each drug that is left out. 
A similar procedure can be applied for the prediction of adverse events through mouse 
phenotypes. Significant pathway-Side effect pairs are replaced with mouse phenotype 
and side effect pairs. Moreover from known targets of each drug that is left out one can 
find the corresponding mouse orthologous genes of these targets. From mouse genes 
relevant mouse phenotypes are extracted and considered as relevant mouse phenotypes to 
the drug that is left out. Next section will summarize our findings and validate prediction 
power of the method.  
6.4 Results and Discussion 
We have selected one example of significant link for each of the pathway-side effect and 
mouse phenotype-side effect networks. Calcium is a common signaling mechanism, as 
once it enters the cytoplasm of a cell it exerts regulatory effects on many enzymes and 
proteins. Calcium can act in signal transduction after influx resulting from activation of 





Heart block is an adverse event term that refers to dysfunction of the electrical system of 
the heart. It can cause syncope and palpitations. Calcium channel and Heart Block are 
found to be significantly related ( giving a p-value<0.0001) in our framework. The targets 
and drugs connecting this pair are shown in figure (6.4).  
 
Figure 6.4 Association of Calcium signaling pathway with Heart Block through 
targets and drugs. 
 
 
For mouse phenotype-adverse event association we found abnormal cardiovascular 
system physiology for mouse is significantly associated with congestive heart failure as 







Figure 6.5 Association of abnormal cardiovascular system physiology for mouse with 
Congestive Heart failure adverse event through targets and drugs. 
 
To validate our method we calculated ROC curve for 708 drugs when each left 
out at a time as it is outlined in section 6.3. Our aim is to predict side effects of a given 
drug using its pathway information. The ROC curve for each drug is averaged over 708 




























 ROC curve average for the prediction of side effects from pathways
 
Figure 6.6 ROC curve average for the prediction of side effects from pathways. 
 
 
Similarly we predicted side effects from mouse phenotypes that are relevant to the drug 
targets.  
 























ROC curve average for side effect prediction from mouse phenotypes
 







As it can be seen from figure (6.6) and figure (6.7) our method is capable of predicting 
side effects from pathways and mouse phenotypes. Furthermore, biologically relevant 
pathway-side effect and phenotype-side effect pairs are found to be significantly 
associated in our method. This study is capable of providing a framework for side effect 
prediction in the early phases of drug development using pathway and animal model 
information. It is very critical to design clinical trial to observe any potential side effect 
risks. At this junction our framework for estimating possible toxicity can be a useful tool. 
This framework can further be extended to include different databases, drug chemical 
structure information and genomic information on targets. 
 
6.2 Conclusions  
 
An adverse event (side effect) is an unwanted and harmful response to a drug that has 
happened during treatment of patients or clinical trials.   Increasing regulatory research is 
focused on the obligation of the medical community, pharmaceutical industry and health 
authorities to ensure that marketed drugs have acceptable benefit-risk profiles. It is 
essential to identify adverse events in the early phases of drug development, therefore 
side effect prediction is critical for pharmaceutical research. Two of these early phases 
include target/pathway discovery and animal models. An adverse event can be caused by 
drugs known targets (target effect) or it can be due to proteins that are not yet identified 
as the targets of the drug (off target effects). Most adverse events are harmful to humans, 
but they can also be utilized to find new uses for known drugs. The knowledge of a 
pathway allows separate targeting of upstream or downstream targets. Inhibition or 





with fewer side effects or better druggability. Furthermore these targets can crosstalk 
with other pathways which may be potential sources of the observed side effects. 
Therefore the knowledge of pathways and their relation to each other helps researchers 
understand side effect profiles [71]. Animal models have specific characteristics that 
mimic human diseases. ]. The laboratory mouse is the premier animal model for 
understanding the genetic and molecular basis of human biology and disease
 
[72].  
In this study we introduced a computational framework for side effect prediction 
from pathway and mouse phenotype information. We integrated MGI, KEGG pathway 
,Drugbank and SIDER information on a multilevel network representation. A p-value 
based approach is introduced to find significant associations between pathway-side effect 
as well as mouse phenotype-side effect pairs. We demonstrated the biological relevance 
of these associations with two examples. Finally, we validated the prediction power of 
our method using ROC curves. 
 It is very critical to design clinical trial to observe any potential side effect risks. 
Our approach can provide a framework for side effect prediction in the early phases of 
drug development using pathway and animal model information. Our framework for 
estimating possible toxicity can be a useful tool. This work can further be extended to 













CONCLUSIONS AND FUTURE EXTENSIONS 
 
It is immensely important to understand biological networks in order to understand 
complex diseases, identify novel, safer protein targets for therapies and design efficient 
drugs. Computational approaches for identifying these networks become crucial and have 
been growing in parallel with the increasing amount of genomic data. „Systems biology‟ 
has emerged as an interdisciplinary science that has as one of its foci revealing biological 
networks through genomic data.  
The contribution of this thesis to Systems Biology can be stated in two ways; 
Predicting biological network topology and dynamics to understand complex machinery 
of biology and finding missing or significant links that have many important applications 
in getting a better picture of the network wiring of the biological systems.  
In chapter 3 we addressed the problem of network identification from noisy 
measurements. It is known that biological data has significant levels of noise. In 
regression from dynamic data the resulting estimation model has noise term in both 
dependent and independent variable. Total Least Squares (TLS) is capable of taking error 
in independent  variables into account. Constrained Total Least Squares (CTLS)  is a 
further improvement on TLS that can incorporate the correlation in the noise.  
We demonstrated the superior performance of our novel CTLS framework over 
other estimation methods on examples with a wide range of data points and noise levels. 
Though CTLS methods seem to improve parameter estimation significantly over the 





it is necessary to use network connectivity data with a combination of optimal 
experimental design to obtain high accuracy parameter estimation.  
In chapter 4 we demonstrated our approach for incorporating prior connectivity 
data with time series data. Binding data provides an initial topology of the gene networks. 
However, this data suffers from high rate of false positive and negative errors. We 
showed that our algorithm is able to fuse connectivity data and micro-array data to 
approach true network topology and dynamics provided that enough data is available.  
However, for reasonable levels of noise in the data (10-20% multiplicative noise) the 
error in parameters is still quite high. This highlights the importance of additional prior 
information. The major problem in topology data is the false negatives, in other words, 
missing links in the prior topology. It is important to be able to identify missing links in 
the prior information.  
Possible extensions: In this method the likelihood term can be improved to 
include noise structure. As we demonstrated in Chapter 3, noise in resulting network 
models is correlated along the time domain. Furthermore noise can be multiplicative in 
nature. This information can be used to improve likelihood expression. 
In chapter 5 we concentrated on link prediction techniques using network‟s 
topological distribution data to address the question of filling in possible false negative 
connections. We introduced a novel link prediction method that is based on local 
connectivity information. The contribution of this work can be summarized in two ways. 
First, our method is a novel and effective computational algorithm to quantify indirect 
relationships between the objects of biological research of interest by using existing 





This method can also be used for different purposes such as; annotating diseases with 
similar aetiology, reposition existing drugs, or discovering adverse events for the targets. 
Second, in a case study involving 9575 proteins in the Ariadne database, our method 
outperformed the Jaccard method for the prediction of existing links for all proteins. This 
illustrates its prediction capability for biological networks. 
Possible extensions: In this work the missing links between pairs of nodes are 
predicted through local connectivity information for the pair of the nodes based on a 
score that is derived from a probabilistic approach. This score function can be further 
extended to consider complementary cumulative distribution for the probability of 
observing shared common nodes with particular in-degree distribution. Complementary 
cumulative function will give one-sided p-value and score function can be based on this 
p-value.  
In chapter 6 we integrated MGI, KEGG pathway, Drugbank and SIDER 
information on a multilevel network representation. A p-value based approach is 
introduced to find significant associations between pathway-side effect as well as mouse 
phenotype-side effect pairs. We demonstrated the biological relevance of these 
associations with two examples. Finally, we validated the prediction power of our method 
using ROC curves. 
  It is very critical to design clinical trial to observe any potential side effect risks. 
Our approach can provide a framework for side effect prediction in the early phases of 
drug development using pathway and animal model information. Our framework for 






Possible extensions: This work can further be extended to include different 
databases, drug chemical information and other genomic resources. AERS database for 
drug-side effect relationships can be used in combination with SIDER. AERS includes 
drug-side effect profiles that have exposure to a larger population compared to clinical 
trial data as in the case of SIDER. Therefore, it can give valuable information on rare side 


































A.1 Bayesian Networks 
 
Bayesian network is a graphical model that represents the causal relationship in random 
variables. Suppose that we have N genes in a graph represented by an array of N random 
variables (expression levels),  1 2,....,, NX X X X . Bayesian networks then enable us to 
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Where jPa  is the set of random variables corresponding to the direct parents of jX  in a 
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where ( )P G  is the prior probability of the graph, ( | )P X G  is the likelihood of the data 
X. ( )P X  is the normalizing constant [20]. 
 
A.2 Dynamic Bayesian Networks 
 
Dynamic Bayesian networks represent the dependency in gene expression levels based on 
time-course data. Suppose that         1 2, ,..., PX t X t X t X t , each being a random 





formulated as a bipartite graph with P  nodes that allows edges from   X t  to  1X t  , 
where, 1,..., 1t N  . The directed graph, TG  of the causal relationship among P  
random variables is then constructed by estimating the bipartite graph. Under this 
topology, one can have the decomposition as follows; 
 
           
1 1




X X t X N X t Pa t
 
  ,   (A.2.1) 
 
Where  jPa t  is the set of random variable at time t corresponding to the direct parent of 
 jX t  in bipartite graph, TG  [20]. In this equation, the distributions are assumed to have 






Figure 10. Graphical view of Dynamic Bayesian Network Model. 
 
In Figure A.2.1, the structure of DBN in case of gene regulation is depicted. Micro-array 
data for different time points are shown in a table form. Each row of the table 







The aim of learning the topology of dynamic Bayesian network is to determine the 
topology, G  that is most probable given data D  (See Equation A.1.2 ).  The notion of 
the most probable network is made formal by the Bayesian scoring metric (BSM), which 
is simply the log posterior probability of G  given D : 
 
       : log | log | logBSM G D G D D G G c        (A.2.2) 
 
This is simply derived by taking the logarithm of bayes rule employed in  equation A.1.2 
A common choice for the log prior over structures,  log G , is to assume that it 
uninformative.: every structure is equally likely: in this case, the prior term can be safely 


























B.1 Systems of Differential Equations 
 
A set of ODEs, one for each gene, describes gene regulation as a function of other genes. 
 
 iiNii UXXXfX ,,,...,, 21                     (B.1.1) 
 
where  i  is a set of parameters describing the interactions among genes (the edges of the 
graph), Ni ...1 , N is the number of genes and iU  is the amount of external perturbation 
applied to the gene.  
 
To reverse-engineer a network using ODEs , a functional form for if  is chosen  and then 
the parameters  i  are estimated from the gene expression data using some optimization 











                     (B.1.2) 
 
where ilX
  is the mRNA concentration of gene i  following the perturbation experiment, 
l ;  
ijA  represent the influence of gene j  on gene i ; ilU  is the external perturbation to the 
expression of gene i  in experiment l  [22]. One can assemble the expressions in a matrix 






UAXX            (B.1.3) 
 
 
B.2 S-Systems Approach  
 









where N is the number of state variables ( gene expression levels), iX . The terms, ,i jg  
and ,i jh  define the effect of jX  on iX . The first term includes all effects that increase 
iX , whereas second term includes the influences that decrease iX . S refers to synergism 
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C.1 Artificial Gene Networks 
 
Mendes et al [16] proposed a nonlinear differential equation system that generates 
random artificial networks according to well-defined kinetic properties. 
In their model, a nonlinear form for if  (right hand side of differential equations 
describing expression level of each gene) is assumed and it is decomposed into two 
components, namely; synthesis and degradation rates.  
 
1( ) ( ,..., ) ( )i i N i ix t S x x D x                               (C.1.1) 
 
where iS  stands for nonlinear synthesis term and iD  is the linear, first order 
degradation. ix is the expression level of 
thi gene. iS  term encompasses the nonlinear 
relation between transcription rate and inhibitor and activator expression levels. One can 
write this relation as;  
 
 
         
                                            (C.1.2) 
 
 
In this formulation, jx  stands for the inhibitor concentrations and j  is the 
inhibitor index for the regulation of gene i . Similarly, kx  accounts for activator 
concentration and k  is the activator index. The exponents jn  and kn  indicates the 
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Here we illustrate how we create, simulate and obtain data from the artificial gene 
network on a simple example. In figure 7, a simple network example is shown. In this 
graph, circles (nodes) indicate the genes and an arrow shows activation. 
 
 
Figure 11: A simple 4-gene network. Gene 1 is the regulator for the rest. It is a single-
input motif. Gene 1 is activating gene number 2 and 4, however it inhibits gene A number 
3.  
 
A connectivity matrix for the example network can be obtained as follows; 
 
 
              
 
                                                         (C.2.1) 
 
0 1 1 1
0 0 0 0
0 0 0 0














Where rows show the indices of the regulator and column numbers correspond to the 
indices of regulated genes. The system of nonlinear differential equations for this graph 
can be written down as follows [16]; 
 
 











x t v d x
x L
 
   
 
            



























x t v d x
x L
 





Simulating this system with an appropriate numerical method, one can obtain time-course 
data in different time intervals. Different levels of Gaussian noise can be added to the 
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